BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-2304. [PMID: 16123508 DOI: 10.2337/diacare.28.9.2289] [Cited by in Crossref: 1431] [Cited by in F6Publishing: 1070] [Article Influence: 89.4] [Reference Citation Analysis]
Number Citing Articles
1 Neuhauser H, Ellert U. Estimation of the metabolic syndrome prevalence in the general population in Germany. J Public Health 2008;16:221-7. [DOI: 10.1007/s10389-007-0168-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Sharma AM, Engeli S. The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome. J Cardiometab Syndr 2006;1:29-35. [PMID: 17675902 DOI: 10.1111/j.0197-3118.2006.05422.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
3 Schneider JG, Tompkins C, Blumenthal RS, Mora S. The metabolic syndrome in women. Cardiol Rev 2006;14:286-91. [PMID: 17053375 DOI: 10.1097/01.crd.0000233757.15181.67] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
4 Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD. Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer. J Cancer Surviv 2007;1:8-16. [DOI: 10.1007/s11764-007-0012-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
5 Fontbonne A, Diouf I, Baccara-Dinet M, Eschwege E, Charles MA. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial. Diabetes Metab 2009;35:385-91. [PMID: 19665415 DOI: 10.1016/j.diabet.2009.03.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
6 Smith MR. Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors. Curr Urol Rep 2008;9:197-202. [PMID: 18765113 DOI: 10.1007/s11934-008-0035-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
7 Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Int J Obes 2007;31:213-20. [DOI: 10.1038/sj.ijo.0803355] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
8 Sun F, Tao Q, Zhan S. Components of metabolic syndrome and the incidence of type 2 diabetes in an elderly Taiwanese cohort. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2009;3:90-5. [DOI: 10.1016/j.dsx.2009.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Fujihara K, Igarashi R, Yamamoto M, Ishizawa M, Matsubayasi Y, Matsunaga S, Kato K, Ito C, Koishi M, Yamanaka N, Kodama S, Sone H. Impact of glucose tolerance status on the development of coronary artery disease among working-age men. Diabetes & Metabolism 2017;43:261-4. [DOI: 10.1016/j.diabet.2016.09.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
10 Gupta AK, Prieto-merino D, Dahlöf B, Sever PS, Poulter NR; on behalf of the ASCOT Investigators. Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach: Metabolic syndrome, impaired fasting glucose, obesity and diabetes. Diabetic Medicine 2011;28:941-7. [DOI: 10.1111/j.1464-5491.2011.03330.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
11 Gallagher EJ, Leroith D, Karnieli E. The metabolic syndrome--from insulin resistance to obesity and diabetes. Med Clin North Am. 2011;95:855-873. [PMID: 21855696 DOI: 10.1016/j.mcna.2011.06.001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
12 Mcmurray RG, Bo Andersen L. The Influence of Exercise on Metabolic Syndrome in Youth: A Review. American Journal of Lifestyle Medicine 2010;4:176-86. [DOI: 10.1177/1559827609351234] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
13 Hirata K, Kume S, Araki S, Sakaguchi M, Chin-Kanasaki M, Isshiki K, Sugimoto T, Nishiyama A, Koya D, Haneda M, Kashiwagi A, Uzu T. Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model. Biochem Biophys Res Commun 2009;380:44-9. [PMID: 19150338 DOI: 10.1016/j.bbrc.2009.01.003] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 9.3] [Reference Citation Analysis]
14 Alberti KGMM, Zimmet P. The metabolic syndrome: Time to reflect. Curr Diab Rep 2006;6:259-61. [DOI: 10.1007/s11892-006-0057-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
15 Wynchank D, Bijlenga D, Lamers F, Kooij JJS, Bron TI, Beekman ATF, Penninx BWJH. The Association Between Metabolic Syndrome, Obesity-Related Outcomes, and ADHD in Adults With Comorbid Affective Disorders. J Atten Disord 2018;22:460-71. [PMID: 27422611 DOI: 10.1177/1087054716659137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
16 Smith SC. Introduction. The American Journal of Medicine 2007;120:S1-2. [DOI: 10.1016/j.amjmed.2007.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Oka R, Kobayashi J, Inazu A, Yagi K, Miyamoto S, Sakurai M, Nakamura K, Miura K, Nakagawa H, Yamagishi M. Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese men. Metabolism 2010;59:748-54. [PMID: 19926101 DOI: 10.1016/j.metabol.2009.09.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
18 Mariotti F, Hermier D, Sarrat C, Magné J, Fénart E, Evrard J, Tomé D, Huneau JF. Rapeseed protein inhibits the initiation of insulin resistance by a high-saturated fat, high-sucrose diet in rats. Br J Nutr 2008;100:984-91. [PMID: 18394216 DOI: 10.1017/S000711450896092X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371:1927-1935. [PMID: 18501419 DOI: 10.1016/s0140-6736(08)60602-9] [Cited by in Crossref: 330] [Cited by in F6Publishing: 116] [Article Influence: 25.4] [Reference Citation Analysis]
20 Sarwar N, Aspelund T, Eiriksdottir G, Gobin R, Seshasai SR, Forouhi NG, Sigurdsson G, Danesh J, Gudnason V. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med. 2010;7:e1000278. [PMID: 20520805 DOI: 10.1371/journal.pmed.1000278] [Cited by in Crossref: 102] [Cited by in F6Publishing: 85] [Article Influence: 9.3] [Reference Citation Analysis]
21 Oda E. Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 2012;49:89-95. [PMID: 21720880 DOI: 10.1007/s00592-011-0309-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 7.8] [Reference Citation Analysis]
22 Tarantino G, Finelli C. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol 2013;19:3375-84. [PMID: 23801829 DOI: 10.3748/wjg.v19.i22.3375] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 95] [Article Influence: 11.5] [Reference Citation Analysis]
23 Anselmino M, Malmberg K, Rydén L, Öhrvik J. A gluco-metabolic risk index with cardiovascular risk stratification potential in patients with coronary artery disease. Diabetes and Vascular Disease Research 2009;6:62-70. [DOI: 10.1177/1479164109336052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Reis MG, Roy NC, Bermingham EN, Ryan L, Bibiloni R, Young W, Krause L, Berger B, North M, Stelwagen K, Reis MM. Impact of Dietary Dairy Polar Lipids on Lipid Metabolism of Mice Fed a High-Fat Diet. J Agric Food Chem 2013;61:2729-38. [DOI: 10.1021/jf303795b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
25 Simons LA, Simons J, Friedlander Y, McCallum J. Is prediction of cardiovascular disease and all-cause mortality genuinely driven by the metabolic syndrome, and independently from its component variables? The Dubbo study. Heart Lung Circ 2011;20:214-9. [PMID: 21353637 DOI: 10.1016/j.hlc.2010.12.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
26 Hwang JH, Kim DW, Jo EJ, Kim YK, Jo YS, Park JH, Yoo SK, Park MK, Kwak TH, Kho YL, Han J, Choi HS, Lee SH, Kim JM, Lee I, Kyung T, Jang C, Chung J, Kweon GR, Shong M. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes 2009;58:965-74. [PMID: 19136651 DOI: 10.2337/db08-1183] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 7.9] [Reference Citation Analysis]
27 Poirier P, Eckel RH. Cardiovascular consequences of obesity. Drug Discovery Today: Therapeutic Strategies 2008;5:45-51. [DOI: 10.1016/j.ddstr.2008.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Sullivan PW, Ghushchyan V, Ben-joseph RH. The Effect of Obesity and Cardiometabolic Risk Factors on Expenditures and Productivity in the United States. Obesity 2008;16:2155-62. [DOI: 10.1038/oby.2008.325] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
29 Ajjan RA, Grant PJ. Cardiovascular disease prevention in patients with type 2 diabetes: the role of oral anti-diabetic agents. Diabetes and Vascular Disease Research 2006;3:147-58. [DOI: 10.3132/dvdr.2006.023] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
30 Hulsmans M, Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med 2010;14:70-8. [PMID: 19968738 DOI: 10.1111/j.1582-4934.2009.00978.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 137] [Article Influence: 12.9] [Reference Citation Analysis]
31 Proença IM, Allegretti JR, Bernardo WM, de Moura DTH, Ponte Neto AM, Matsubayashi CO, Flor MM, Kotinda APST, de Moura EGH. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials. Nutr Res 2020;83:1-14. [PMID: 32987284 DOI: 10.1016/j.nutres.2020.06.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
32 Li S, Yin C, Zhao W, Zhu H, Xu D, Xu Q, Jiao Y, Wang X, Qiao H. Homeostasis model assessment of insulin resistance in relation to the poor functional outcomes in nondiabetic patients with ischemic stroke. Biosci Rep 2018;38:BSR20180330. [PMID: 29588341 DOI: 10.1042/BSR20180330] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
33 Baynouna LM, Revel AD, Nagelkerke NJ, Jaber TM, Omar AO, Ahmed NM, Nazirudeen MK, Al Sayed MF, Nour FA, Abdouni S. Associations of cardiovascular risk factors in Al Ain, United Arab Emirates. Cardiovasc Diabetol 2009;8:21. [PMID: 19371412 DOI: 10.1186/1475-2840-8-21] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
34 Lee M, Hsiao P, Huang J, Hsu W, Chen S, Shin S. Association Between Metabolic Syndrome and Microvascular and Macrovascular Disease in Type 2 Diabetic Mellitus. The American Journal of the Medical Sciences 2018;355:342-9. [DOI: 10.1016/j.amjms.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Gerber TC, Taylor AJ. Carotid Intima-Media Thickness: Can It Close the “Detection Gap” for Cardiovascular Risk? Mayo Clinic Proceedings 2009;84:218-20. [DOI: 10.4065/84.3.218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
36 Szigethy E, Széles G, Horváth A, Hidvégi T, Jermendy G, Paragh G, Blaskó G, Ádány R, Vokó Z. Epidemiology of the metabolic syndrome in Hungary. Public Health 2012;126:143-9. [DOI: 10.1016/j.puhe.2011.11.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
37 Mulè G, Calcaterra I, Nardi E, Cerasola G, Cottone S. Metabolic syndrome in hypertensive patients: An unholy alliance. World J Cardiol 2014;6:890-907. [PMID: 25276291 DOI: 10.4330/wjc.v6.i9.890] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
38 Bruno G, Fornengo P, Segre O, Novelli G, Panero F, Perotto M, Zucco C, Bargero G, Cavallo-Perin P. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study. J Hypertens 2009;27:2403-8. [PMID: 19738492 DOI: 10.1097/HJH.0b013e3283310ee5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
39 Lind L, Sundström J, Ärnlöv J, Risérus U, Lampa E. A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases. Sci Rep 2021;11:2978. [PMID: 33536506 DOI: 10.1038/s41598-021-82398-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Worm SW, Lundgren JD. The metabolic syndrome in HIV. Best Practice & Research Clinical Endocrinology & Metabolism 2011;25:479-86. [DOI: 10.1016/j.beem.2010.10.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
41 Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome. The Lancet 2005;366:1921-2. [DOI: 10.1016/s0140-6736(05)67778-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
42 Kaaja RJ. Metabolic syndrome and the menopause. Menopause International 2008;14:21-5. [DOI: 10.1258/mi.2007.007032] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
43 Plaza-Díaz J, Robles-Sánchez C, Abadía-Molina F, Morón-Calvente V, Sáez-Lara MJ, Ruiz-Bravo A, Jiménez-Valera M, Gil Á, Gómez-Llorente C, Fontana L. Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains. Sci Rep 2017;7:1939. [PMID: 28512356 DOI: 10.1038/s41598-017-02203-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
44 Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375:181-183. [PMID: 20109902 DOI: 10.1016/s0140-6736(09)61794-3] [Cited by in Crossref: 612] [Cited by in F6Publishing: 255] [Article Influence: 55.6] [Reference Citation Analysis]
45 Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol. 2005;25:2243-2244. [PMID: 16258150 DOI: 10.1161/01.atv.0000189155.75833.c7] [Cited by in Crossref: 149] [Cited by in F6Publishing: 57] [Article Influence: 9.9] [Reference Citation Analysis]
46 Meirelles RMR. Menopausa e síndrome metabólica. Arq Bras Endocrinol Metab 2014;58:91-6. [DOI: 10.1590/0004-2730000002909] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
47 Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol 2014;220:T1-T23. [PMID: 24281010 DOI: 10.1530/JOE-13-0327] [Cited by in Crossref: 201] [Cited by in F6Publishing: 165] [Article Influence: 28.7] [Reference Citation Analysis]
48 Tung A. Anaesthetic considerations with the metabolic syndrome. Br J Anaesth 2010;105 Suppl 1:i24-33. [PMID: 21148652 DOI: 10.1093/bja/aeq293] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
49 Saland JM. Update on the metabolic syndrome in children. Curr Opin Pediatr 2007;19:183-91. [PMID: 17496763 DOI: 10.1097/MOP.0b013e3280208519] [Cited by in Crossref: 72] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
50 Razzouk L, Muntner P. Ethnic, gender, and age-related differences in patients with the metabolic syndrome. Curr Hypertens Rep 2009;11:127-32. [PMID: 19278602 DOI: 10.1007/s11906-009-0023-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
51 Dessein PH, Woodiwiss AJ, Joffe BI, Norton GR. Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis. BMC Cardiovasc Disord 2007;7:31. [PMID: 17967187 DOI: 10.1186/1471-2261-7-31] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
52 Reaven G. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: the end of the beginning. Circulation 2005;112:3030-2. [PMID: 16286599 DOI: 10.1161/CIRCULATIONAHA.105.504670] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
53 Ezenwaka CE, Nwagbara E, Seales D, Okali F, Hussaini S, Raja B, Wheeler V, Sell H, Avci H, Eckel J. A comparative study of the prevalence of the metabolic syndrome and its components in type 2 diabetic patients in two Caribbean islands using the new International Diabetes Federation definition. Arch Physiol Biochem 2007;113:202-10. [PMID: 17852050 DOI: 10.1080/13813450701475201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
54 Wang L, Zhang Y, Chen S, Chen J, Zhuang Y, Chen J. Association of metabolic syndrome and IgA nephropathy. J Clin Pathol 2010;63:697-701. [PMID: 20702470 DOI: 10.1136/jcp.2009.074278] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
55 Zaharia OP, Bobrov P, Strassburger K, Bódis K, Karusheva Y, Scholz M, Markgraf DF, Burkart V, Schloot NC, Müssig K, Szendroedi J, Roden M; GDS Group. Metabolic Characteristics of Recently Diagnosed Adult-Onset Autoimmune Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2018;103:429-37. [DOI: 10.1210/jc.2017-01706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
56 Hobbs FD. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control. Int J Cardiol 2006;110:137-45. [PMID: 16289373 DOI: 10.1016/j.ijcard.2005.09.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
57 Stern N, Izkhakov Y. The metabolic syndrome revisited: "cardiometabolic risk" emerges as common ground between differing views of the ADA and AHA. J Cardiometab Syndr 2006;1:362-3. [PMID: 17679794 DOI: 10.1111/j.1524-6175.2006.05999.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
58 Lee AM, Gurka MJ, DeBoer MD. A metabolic syndrome severity score to estimate risk in adolescents and adults: current evidence and future potential. Expert Rev Cardiovasc Ther. 2016;14:411-413. [PMID: 26783022 DOI: 10.1586/14779072.2016.1143360] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
59 Noctor E, Crowe C, Carmody LA, Kirwan B, O’dea A, Glynn LG, Mcguire BE, O’shea PM, Dunne FP. ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Acta Diabetol 2015;52:153-60. [DOI: 10.1007/s00592-014-0621-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
60 Okosun IS, Lyn R, Davis-Smith M, Eriksen M, Seale P. Validity of a continuous metabolic risk score as an index for modeling metabolic syndrome in adolescents. Ann Epidemiol 2010;20:843-51. [PMID: 20933191 DOI: 10.1016/j.annepidem.2010.08.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
61 Mishra I, Jones C, Patel V, Deodhar S, Cistola DP. Early detection of metabolic dysregulation using water T2 analysis of biobanked samples. Diabetes Metab Syndr Obes 2018;11:807-18. [PMID: 30538517 DOI: 10.2147/DMSO.S180655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 López-Suárez A, Bascuñana-Quirell A, Beltrán-Robles M, Elvira-González J, Fernández-Palacín F, Barroso-Casamitjana E, Solino-Ocaña I. Metabolic syndrome does not improve the prediction of 5-year cardiovascular disease and total mortality over standard risk markers. Prospective population based study. Medicine (Baltimore) 2014;93:e212. [PMID: 25501079 DOI: 10.1097/MD.0000000000000212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Arsenault BJ, Beaumont EP, Després JP, Larose E. Mapping body fat distribution: a key step towards the identification of the vulnerable patient? Ann Med. 2012;44:758-772. [PMID: 22149719 DOI: 10.3109/07853890.2011.605387] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
64 Morales AM, Mirone V, Dean J, Costa P. Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence. Clin Interv Aging 2009;4:463-72. [PMID: 20054411 DOI: 10.2147/cia.s3878] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Reinehr T, Wunsch R, de Sousa G, Toschke AM. Relationship between metabolic syndrome definitions for children and adolescents and intima-media thickness. Atherosclerosis 2008;199:193-200. [DOI: 10.1016/j.atherosclerosis.2007.09.041] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
66 Durazzo M, Belci P, Collo A, Prandi V, Pistone E, Martorana M, Gambino R, Bo S. Gender specific medicine in liver diseases: a point of view. World J Gastroenterol. 2014;20:2127-2135. [PMID: 24605011 DOI: 10.3748/wjg.v20.i9.2127] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
67 Ritz E. Metabolic syndrome and kidney disease. Blood Purif. 2008;26:59-62. [PMID: 18182798 DOI: 10.1159/000110566] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
68 Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008;10:156-64. [PMID: 18474184 DOI: 10.1007/s11906-008-0029-7] [Cited by in Crossref: 106] [Cited by in F6Publishing: 92] [Article Influence: 8.2] [Reference Citation Analysis]
69 Wallace HJ, Holmes L, Ennis CN, Cardwell CR, Woodside JV, Young IS, Bell PM, Hunter SJ, McKinley MC. Effect of vitamin D3 supplementation on insulin resistance and β-cell function in prediabetes: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2019;110:1138-47. [PMID: 31559433 DOI: 10.1093/ajcn/nqz171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
70 Nazare J, Balkau B, Borel A. The Metabolic Syndrome. In: Reusch, Md JEB, Regensteiner, Phd, Ma, Ba JG, Stewart, Ed.d., Faha, Maacvpr, Facs KJ, Veves, Md, Dsc A, editors. Diabetes and Exercise. Cham: Springer International Publishing; 2018. pp. 31-45. [DOI: 10.1007/978-3-319-61013-9_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Cusi K. The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity. In: Regensteiner JG, Reusch JE, Stewart KJ, Veves A, editors. Diabetes and Exercise. Totowa: Humana Press; 2009. pp. 3-54. [DOI: 10.1007/978-1-59745-260-1_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
72 Gurka MJ, Lilly CL, Oliver MN, DeBoer MD. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Metabolism. 2014;63:218-225. [PMID: 24290837 DOI: 10.1016/j.metabol.2013.10.006] [Cited by in Crossref: 90] [Cited by in F6Publishing: 66] [Article Influence: 11.3] [Reference Citation Analysis]
73 Meysamie A, Ghalehtaki R, Ghodsi S, Mohebi M, Ghalehtaki S, Salarvand F, Hosseini Z, Sadre-Bafghi SA. Is there an independent association between metabolic syndrome and smoking in Iranian adults? Results of a large multicenter national survey. Caspian J Intern Med 2021;12:327-35. [PMID: 34221284 DOI: 10.22088/cjim.12.3.327] [Reference Citation Analysis]
74 Corella D. Gene-alcohol interactions in the metabolic syndrome. Nutr Metab Cardiovasc Dis 2007;17:140-7. [PMID: 17008075 DOI: 10.1016/j.numecd.2006.02.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
75 Neuhouser ML, Howard B, Lu J, Tinker LF, Van Horn L, Caan B, Rohan T, Stefanick ML, Thomson CA. A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: the Women's Health Initiative. Metabolism 2012;61:1572-81. [PMID: 22633601 DOI: 10.1016/j.metabol.2012.04.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
76 Hulsmans M, Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med. 2010;14:70-78. [PMID: 19968738 DOI: 10.1096/fj.11-181149] [Cited by in Crossref: 156] [Cited by in F6Publishing: 142] [Article Influence: 13.0] [Reference Citation Analysis]
77 Ingelsson E, Hulthe J, Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest. 2008;38:502-509. [PMID: 18489581 DOI: 10.1111/j.1365-2362.2008.01962.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
78 Ukegbu UJ, Castillo DC, Knight MG, Ricks M, Miller BV 3rd, Onumah BM, Sumner AE. Metabolic syndrome does not detect metabolic risk in African men living in the U.S. Diabetes Care 2011;34:2297-9. [PMID: 21873563 DOI: 10.2337/dc11-1055] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
79 Hruz PW. HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models. Curr Opin HIV AIDS 2008;3:660-5. [PMID: 19373039 DOI: 10.1097/COH.0b013e3283139134] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
80 Pratley RE. Metabolic syndrome: Why the controversy? Curr Diab Rep 2007;7:56-9. [DOI: 10.1007/s11892-007-0010-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
81 Daudon M, Traxer O, Conort P, Lacour B, Jungers P. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol. 2006;17:2026-2033. [PMID: 16775030 DOI: 10.1681/asn.2006030262] [Cited by in Crossref: 177] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
82 Mazza A, Zamboni S, Tikhonoff V, Scarpa R, Cuppini S, Zennaro R, Pessina AC, Casiglia E. Pulse hypertension: a new component of the metabolic syndrome in elderly women? J Hum Hypertens 2007;21:934-41. [DOI: 10.1038/sj.jhh.1002245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
83 Davidson JA, Kannel WB, Lopez-Candales A, Morales L, Moreno PR, Ovalle F, Rodriguez CJ, Rodbard HW, Rosenson RS, Stern M. Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action. J Cardiometab Syndr 2007;2:238-43. [PMID: 18059205 DOI: 10.1111/j.1559-4564.2007.07534.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
84 Martens FM, Visseren FL. The operative risk factors in the metabolic syndrome: is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity. Curr Diab Rep 2007;7:74-81. [PMID: 17254521 DOI: 10.1007/s11892-007-0013-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Mcintyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, Konarski JZ, Kennedy SH. Medical comorbidity in bipolar disorder: reprioritizing unmet needs: . Current Opinion in Psychiatry 2007;20:406-16. [DOI: 10.1097/yco.0b013e3281938102] [Cited by in Crossref: 91] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
86 Scuteri A, Laurent S, Cucca F, Cockcroft J, Cunha PG, Mañas LR, Mattace Raso FU, Muiesan ML, Ryliškytė L, Rietzschel E, Strait J, Vlachopoulos C, Völzke H, Lakatta EG, Nilsson PM; Metabolic Syndrome and Arteries Research (MARE) Consortium. Metabolic syndrome across Europe: different clusters of risk factors. Eur J Prev Cardiol 2015;22:486-91. [PMID: 24647805 DOI: 10.1177/2047487314525529] [Cited by in Crossref: 121] [Cited by in F6Publishing: 96] [Article Influence: 17.3] [Reference Citation Analysis]
87 Zanoli L, Empana JP, Estrugo N, Escriou G, Ketthab H, Pruny JF, Castellino P, Laude D, Thomas F, Pannier B, Jouven X, Boutouyrie P, Laurent S. The Neural Baroreflex Pathway in Subjects With Metabolic Syndrome: A Sub-Study of the Paris Prospective Study III. Medicine (Baltimore) 2016;95:e2472. [PMID: 26765449 DOI: 10.1097/MD.0000000000002472] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
88 Hosseinpanah F, Asghari G, Barzin M, Golkashani HA, Azizi F. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults. International Journal of Cardiology 2013;168:369-74. [DOI: 10.1016/j.ijcard.2012.09.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
89 Benyamin B, Sørensen TIA, Schousboe K, Fenger M, Visscher PM, Kyvik KO. Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome? Diabetologia 2007;50:1880-8. [PMID: 17624514 DOI: 10.1007/s00125-007-0758-1] [Cited by in Crossref: 89] [Cited by in F6Publishing: 70] [Article Influence: 6.4] [Reference Citation Analysis]
90 Geor RJ, Harris P. Dietary Management of Obesity and Insulin Resistance: Countering Risk for Laminitis. Veterinary Clinics of North America: Equine Practice 2009;25:51-65. [DOI: 10.1016/j.cveq.2009.02.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
91 Wang S, Huang M, You X, Zhao J, Chen L, Wang L, Luo Y, Chen Y. Gut microbiota mediates the anti-obesity effect of calorie restriction in mice. Sci Rep 2018;8:13037. [PMID: 30158649 DOI: 10.1038/s41598-018-31353-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 20.0] [Reference Citation Analysis]
92 Ooi GJ, Doyle L, Tie T, Wentworth JM, Laurie C, Earnest A, Cowley MA, Sikaris K, le Roux CW, Burton PR, O'Brien PE, Brown WA. Weight loss after laparoscopic adjustable gastric band and resolution of the metabolic syndrome and its components. Int J Obes (Lond) 2017;41:902-8. [PMID: 28262677 DOI: 10.1038/ijo.2017.59] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
93 Evangelista O, McLaughlin MA. Review of cardiovascular risk factors in women. Gend Med 2009;6 Suppl 1:17-36. [PMID: 19318217 DOI: 10.1016/j.genm.2009.02.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
94 Szendroedi J, Saxena A, Weber KS, Strassburger K, Herder C, Burkart V, Nowotny B, Icks A, Kuss O, Ziegler D, Al-Hasani H, Müssig K, Roden M; GDS Group. Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol 2016;15:59. [PMID: 27053136 DOI: 10.1186/s12933-016-0374-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 11.4] [Reference Citation Analysis]
95 Santini F, Giannetti M, Mazzeo S, Fierabracci P, Scartabelli G, Marsili A, Valeriano R, Pucci A, Anselmino M, Zampa V, Vitti P, Pinchera A. Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women. J Endocrinol Invest 2007;30:104-10. [DOI: 10.1007/bf03347407] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
96 Tomé MA, Botana MA, Cadarso-Suárez C, Rego-Iraeta A, Fernández-Mariño A, Mato JA, Solache I, Perez-Fernandez R. Prevalence of metabolic syndrome in Galicia (NW Spain) on four alternative definitions and association with insulin resistance. J Endocrinol Invest 2009;32:505-11. [PMID: 19465797 DOI: 10.1007/BF03346497] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
97 Wong ND. Metabolic Syndrome: Cardiovascular Risk Assessment and Management. American Journal of Cardiovascular Drugs 2007;7:259-72. [DOI: 10.2165/00129784-200707040-00004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
98 Deedwania P, Barter P, Carmena R, Fruchart J, Grundy SM, Haffner S, Kastelein JJ, Larosa JC, Schachner H, Shepherd J, Waters DD. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. The Lancet 2006;368:919-28. [DOI: 10.1016/s0140-6736(06)69292-1] [Cited by in Crossref: 281] [Cited by in F6Publishing: 53] [Article Influence: 18.7] [Reference Citation Analysis]
99 Terán-García M, Bouchard C. Genetics of the metabolic syndrome. Appl Physiol Nutr Metab 2007;32:89-114. [PMID: 17332787 DOI: 10.1139/h06-102] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
100 Barbero A, Astiz S, Lopez-Bote CJ, Perez-Solana ML, Ayuso M, Garcia-Real I, Gonzalez-Bulnes A. Maternal malnutrition and offspring sex determine juvenile obesity and metabolic disorders in a swine model of leptin resistance. PLoS One 2013;8:e78424. [PMID: 24205230 DOI: 10.1371/journal.pone.0078424] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
101 Tsatsoulis A, Mantzaris MD, Bellou S, Andrikoula M. Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment - an evolutionary perspective. Metabolism 2013;62:622-33. [PMID: 23260798 DOI: 10.1016/j.metabol.2012.11.004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 69] [Article Influence: 9.9] [Reference Citation Analysis]
102 Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918. [PMID: 16380542 DOI: 10.1161/circulationaha.106.171016] [Cited by in Crossref: 1712] [Cited by in F6Publishing: 635] [Article Influence: 107.0] [Reference Citation Analysis]
103 Lebiedz-Odrobina D, Kay J. Rheumatic manifestations of diabetes mellitus. Rheum Dis Clin North Am 2010;36:681-99. [PMID: 21092846 DOI: 10.1016/j.rdc.2010.09.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
104 Kondo T, Osugi S, Shimokata K, Honjo H, Morita Y, Yamashita K, Maeda K, Muramatsu T, Shintani S, Matsushita K, Murohara T. Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men. Eur J Cardiovasc Prev Rehabil 2011;18:574-80. [PMID: 21450628 DOI: 10.1177/1741826710389529] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
105 Guiducci L, Järvisalo M, Kiss J, Någren K, Viljanen A, Naum AG, Gastaldelli A, Savunen T, Knuuti J, Salvadori PA, Ferrannini E, Nuutila P, Iozzo P. [11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia. Nucl Med Biol 2006;33:521-8. [PMID: 16720244 DOI: 10.1016/j.nucmedbio.2006.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
106 Vergnaud AC, Protogerou AD, Li Y, Czernichow S, Vesin C, Blacher J, Safar ME. Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy: The role of heart rate. Atherosclerosis 2008;199:222-9. [DOI: 10.1016/j.atherosclerosis.2007.09.033] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
107 Ranjith N, Pegoraro RJ, Naidoo DP, Shanmugam R, Rom L. Genetic variants associated with insulin resistance and metabolic syndrome in young Asian Indians with myocardial infarction. Metab Syndr Relat Disord. 2008;6:209-214. [PMID: 18710329 DOI: 10.1089/met.2008.0023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
108 Rueda-clausen CF, Lahera V, Calderón J, Bolivar IC, Castillo VR, Gutiérrez M, Carreño M, Oubiña MDP, Cachofeiro V, López-jaramillo P. The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors. International Journal of Cardiology 2010;139:32-41. [DOI: 10.1016/j.ijcard.2008.09.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
109 Zarich S, Luciano C, Hulford J, Abdullah A. Prevalence of metabolic syndrome in young patients with acute MI: does the Framingham Risk Score underestimate cardiovascular risk in this population? Diabetes and Vascular Disease Research 2006;3:103-7. [DOI: 10.3132/dvdr.2006.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
110 Khan U, Sowers JR. Cardiometabolic syndrome and thyroid dysfunction. J Cardiometab Syndr 2007;2:81-3. [PMID: 17684467 DOI: 10.1111/j.1559-4564.2007.06168.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
111 Chung SD, Chien CT, Yu HJ. Alterations in peripheral purinergic and muscarinic signaling of rat bladder after long-term fructose-induced metabolic syndrome. Eur J Nutr 2013;52:347-59. [PMID: 22426756 DOI: 10.1007/s00394-012-0342-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
112 Tentolouris N, Argyrakopoulou G, Katsilambros N. Perturbed autonomic nervous system function in metabolic syndrome. Neuromolecular Med 2008;10:169-78. [PMID: 18224460 DOI: 10.1007/s12017-008-8022-5] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
113 Albarwani SA, Bayoumi RA, Jaju D, Al-yahyaee SA, Al-hadabi S, Lopez-alvarenga JC, Comuzzie AG, Hassan MO. Differing Definition-Based Prevalence of Metabolic Syndrome in the Women of Oman Family Study: A Function of Multiparity. Metabolic Syndrome and Related Disorders 2008;6:197-202. [DOI: 10.1089/met.2008.0009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
114 Barajas-Martínez A, Easton JF, Rivera AL, Martínez-Tapia R, de la Cruz L, Robles-Cabrera A, Stephens CR. Metabolic Physiological Networks: The Impact of Age. Front Physiol 2020;11:587994. [PMID: 33117199 DOI: 10.3389/fphys.2020.587994] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
115 Zhang WW, Liu CY, Wang YJ, Xu ZQ, Chen Y, Zhou HD. Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. J Neurol 2009;256:1493-9. [PMID: 19533205 DOI: 10.1007/s00415-009-5150-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
116 Friedewald VE, Leiter LA, Mcguire DK, Nesto RW, Roberts WC. The Editor’s Roundtable: Diabetes Mellitus and Coronary Heart Disease. The American Journal of Cardiology 2006;98:842-56. [DOI: 10.1016/j.amjcard.2006.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
117 Fujiyoshi A, Murad MH, Luna M, Rosario A, Ali S, Paniagua D, Molina J, Lopez M, Jacobs S, Lopez-jimenez F. Metabolic syndrome and its components are underdiagnosed in cardiology clinics: Metabolic syndrome is underdiagnosed. Journal of Evaluation in Clinical Practice 2011;17:78-83. [DOI: 10.1111/j.1365-2753.2010.01371.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
118 Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation. 2007;115:1345-1353. [PMID: 17339551 DOI: 10.1161/circulationaha.106.655142] [Cited by in Crossref: 148] [Cited by in F6Publishing: 69] [Article Influence: 10.6] [Reference Citation Analysis]
119 Watson K. Managing Cardiometabolic Risk: An Evolving Approach to Patient Care. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 2007;6:5-14. [DOI: 10.1097/01.hpc.0000255063.43838.6d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
120 Mayer-Davis EJ, Ma B, Lawson A, D'Agostino RB Jr, Liese AD, Bell RA, Dabelea D, Dolan L, Pettitt DJ, Rodriguez BL, Williams D; SEARCH for Diabetes in Youth Study Group. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord 2009;7:89-95. [PMID: 18847385 DOI: 10.1089/met.2008.0046] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
121 Lobley GE, Bremner DM, Holtrop G, Johnstone AM, Maloney C. Impact of high-protein diets with either moderate or low carbohydrate on weight loss, body composition, blood pressure and glucose tolerance in rats. Br J Nutr 2007;97:1099-108. [DOI: 10.1017/s0007114507691934] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
122 Simons LA, Simons J, Friedlander Y, Mccallum J. Does a diagnosis of the metabolic syndrome provide additional prediction of cardiovascular disease and total mortality in the elderly? The Dubbo Study. Medical Journal of Australia 2007;186:400-3. [DOI: 10.5694/j.1326-5377.2007.tb00972.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
123 Shimajiri Y, Tsunoda K, Furuta M, Kadoya Y, Yamada S, Nanjo K, Sanke T. Prevalence of metabolic syndrome in Japanese type 2 diabetic patients and its significance for chronic vascular complications. Diabetes Res Clin Pract 2008;79:310-7. [PMID: 17933413 DOI: 10.1016/j.diabres.2007.08.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
124 Chailurkit LO, Aekplakorn W, Paiyabhroma N, Ongphiphadhanakul B. Global 11 Beta-Hydroxysteroid Dehydrogenase Activity Assessed by the Circulating Cortisol to Cortisone Ratio is Associated with Features of Metabolic Syndrome. Metab Syndr Relat Disord 2020;18:291-5. [PMID: 32357081 DOI: 10.1089/met.2020.0013] [Reference Citation Analysis]
125 Kim HL, Joo HJ, Lim WH, Seo JB, Kim SH, Zo JH, Lim DS, Kim MA. Association Between Metabolic Syndrome and Parameters of Subclinical Target Organ Damage in Urban Subjects Without Documented Cardiovascular Disease. Metab Syndr Relat Disord 2020;18:373-80. [PMID: 32721264 DOI: 10.1089/met.2020.0026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Krentz AJ, Viljoen A, Sinclair A. Insulin resistance: a risk marker for disease and disability in the older person. Diabet Med 2013;30:535-48. [DOI: 10.1111/dme.12063] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
127 Kawamoto R, Ninomiya D, Kasai Y, Kusunoki T, Ohtsuka N, Kumagi T, Abe M. Handgrip strength is associated with metabolic syndrome among middle-aged and elderly community-dwelling persons. Clin Exp Hypertens 2016;38:245-51. [PMID: 26818203 DOI: 10.3109/10641963.2015.1081232] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
128 Borovoy A. Japan's Public Health Paradigm: Governmentality and the Containment of Harmful Behavior. Med Anthropol 2017;36:32-46. [PMID: 27002929 DOI: 10.1080/01459740.2016.1148033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
129 Wu G, Collins JK, Perkins-veazie P, Siddiq M, Dolan KD, Kelly KA, Heaps CL, Meininger CJ. Dietary Supplementation with Watermelon Pomace Juice Enhances Arginine Availability and Ameliorates the Metabolic Syndrome in Zucker Diabetic Fatty Rats. The Journal of Nutrition 2007;137:2680-5. [DOI: 10.1093/jn/137.12.2680] [Cited by in Crossref: 142] [Cited by in F6Publishing: 111] [Article Influence: 10.1] [Reference Citation Analysis]
130 Cheng TO. Prevention of cardiovascular disease in modern China: Utile or futile? CVD Prevention and Control 2009;4:1-7. [DOI: 10.1016/j.cvdpc.2008.11.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
131 Abramovitz I, Zini A, Pribluda P, Kedem R, Zur D, Protter NE, Almoznino G. "Dental Cluster" Versus "Metabolic Cluster": Analyzing the Associations of Planned and Delivered Dental Procedures with Metabolic Syndrome, Utilizing Data from the Dental, Oral, Medical Epidemiological (DOME) Cross-Sectional Record-Based Nationwide Study. Biology (Basel) 2021;10:608. [PMID: 34209432 DOI: 10.3390/biology10070608] [Reference Citation Analysis]
132 Dusseault-Belanger F, Cohen AA, Hivert MF, Courteau J, Vanasse A. Validating metabolic syndrome through principal component analysis in a medically diverse, realistic cohort. Metab Syndr Relat Disord 2013;11:21-8. [PMID: 22978288 DOI: 10.1089/met.2012.0094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
133 Bays HE, Chapman RH, Grandy S; SHIELD Investigators' Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007;61:737-47. [PMID: 17493087 DOI: 10.1111/j.1742-1241.2007.01336.x] [Cited by in Crossref: 247] [Cited by in F6Publishing: 194] [Article Influence: 17.6] [Reference Citation Analysis]
134 Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237-4245. [PMID: 16940456 DOI: 10.1210/jc.2006-0178] [Cited by in Crossref: 1248] [Cited by in F6Publishing: 786] [Article Influence: 83.2] [Reference Citation Analysis]
135 Penninx BW, Nicklas BJ, Newman AB, Harris TB, Goodpaster BH, Satterfield S, de Rekeneire N, Yaffe K, Pahor M, Kritchevsky SB; Health ABC Study. Metabolic syndrome and physical decline in older persons: results from the Health, Aging And Body Composition Study. J Gerontol A Biol Sci Med Sci 2009;64:96-102. [PMID: 19164274 DOI: 10.1093/gerona/gln005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
136 Fessler MB, Rudel LL, Brown JM. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol. 2009;20:379-385. [PMID: 19625959 DOI: 10.1097/mol.0b013e32832fa5c4] [Cited by in Crossref: 166] [Cited by in F6Publishing: 78] [Article Influence: 13.8] [Reference Citation Analysis]
137 Darsow T, Kendall D, Maggs D. Is the metabolic syndrome a real clinical entity and should it receive drug treatment? Curr Diab Rep 2006;6:357-64. [PMID: 17076996 DOI: 10.1007/s11892-006-0006-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
138 Grundy S. Toward optimal health: Scott Grundy, M.D., Ph.D. discusses metabolic syndrome ( interviewed by Jodi R. Godfrey). J Womens Health (Larchmt) 2005;14:883-8. [PMID: 16372889 DOI: 10.1089/jwh.2005.14.883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
139 Wang X, Liang L, Junfen FU, Lizhong DU. Metabolic syndrome in obese children born large for gestational age. Indian J Pediatr 2007;74:561-5. [PMID: 17595499 DOI: 10.1007/s12098-007-0108-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
140 D'Oria R, Laviola L, Giorgino F, Unfer V, Bettocchi S, Scioscia M. PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia. Pregnancy Hypertens 2017;10:107-12. [PMID: 29153661 DOI: 10.1016/j.preghy.2017.07.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
141 Haroon M, Gallagher P, Heffernan E, FitzGerald O. High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol. 2014;41:1357-1365. [PMID: 24931949 DOI: 10.3899/jrheum.140021] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 12.9] [Reference Citation Analysis]
142 Boursier V. Le syndrome métabolique. Journal des Maladies Vasculaires 2006;31:190-201. [DOI: 10.1016/s0398-0499(06)76543-x] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
143 Georgousopoulou EN, Kouli G, Panagiotakos DB, Kalogeropoulou A, Zana A, Chrysohoou C, Tsigos C, Tousoulis D, Stefanadis C, Pitsavos C. Anti-inflammatory diet and 10-year (2002–2012) cardiovascular disease incidence: The ATTICA study. International Journal of Cardiology 2016;222:473-8. [DOI: 10.1016/j.ijcard.2016.08.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
144 Llabre MM, Arguelles W, Schneiderman N, Gallo LC, Daviglus ML, Chambers EC, Sotres-Alvarez D, Chirinos DA, Talavera GA, Castaneda SF, Roesch SC, Heiss G. Do all components of the metabolic syndrome cluster together in U.S. Hispanics/Latinos? Results from the Hispanic Community Health study/Study of Latinos. Ann Epidemiol 2015;25:480-5. [PMID: 25818844 DOI: 10.1016/j.annepidem.2015.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
145 Guize L, Pannier B, Thomas F, Bean K, Jégo B, Benetos A. Recent advances in metabolic syndrome and cardiovascular disease. Arch Cardiovasc Dis. 2008;101:577-583. [PMID: 19041842 DOI: 10.1016/j.acvd.2008.06.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
146 Mannucci E, Monami M, Bardini G, Ognibene A, Rotella CM. National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: Results from the FIBAR Study. J Endocrinol Invest 2007;30:925-30. [DOI: 10.1007/bf03349239] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
147 Chien K, Hsu H, Lee Y, Chen M. Renal function and metabolic syndrome components on cardiovascular and all-cause mortality. Atherosclerosis 2008;197:860-7. [DOI: 10.1016/j.atherosclerosis.2007.07.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
148 Chan DC, Barrett PH, Watts GF. Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Curr Opin Lipidol 2006;17:28-36. [PMID: 16407713 DOI: 10.1097/01.mol.0000199815.46720.ca] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
149 Després J, Cartier A, Côté M, Arsenault BJ. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology. Annals of Medicine 2009;40:514-23. [DOI: 10.1080/07853890802004959] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
150 Woodward M, Tunstall-pedoe H. The metabolic syndrome is not a sensible tool for predicting the risk of coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation 2009;16:210-4. [DOI: 10.1097/hjr.0b013e3283282f8d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
151 Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein AC, Lin P, Champagne CM, King AC, Mcguire HL, Stevens VJ, Brantley PJ, Harsha DW, Mcburnie MA, Appel LJ, Svetkey LP. Effects of PREMIER Lifestyle Modifications on Participants With and Without the Metabolic Syndrome. Hypertension 2007;50:609-16. [DOI: 10.1161/hypertensionaha.107.089458] [Cited by in Crossref: 78] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
152 Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006;188:231-44. [PMID: 16581078 DOI: 10.1016/j.atherosclerosis.2006.02.010] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 7.4] [Reference Citation Analysis]
153 Mertens I, Van Gaal LF. New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome. J Thromb Haemost 2006;4:1164-6. [PMID: 16689783 DOI: 10.1111/j.1538-7836.2006.01919.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
154 Cioffi G, Viapiana O, Tarantini L, Orsolini G, Idolazzi L, Sonographer FO, Dalbeni A, Gatti D, Fassio A, Rossini M, Giollo A. Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome. Intern Emerg Med 2021;16:863-74. [PMID: 33083946 DOI: 10.1007/s11739-020-02520-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Tomlinson JW, Tchernof A. Special issue on Steroids in Obesity and Diabetes. J Steroid Biochem Mol Biol 2010;122:1-2. [PMID: 20832011 DOI: 10.1016/j.jsbmb.2010.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
156 Sheu WH, Tseng YH. Uric acid: an additional component of metabolic syndrome? J Chin Med Assoc 2006;69:99-100. [PMID: 16599012 DOI: 10.1016/S1726-4901(09)70184-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
157 Penno G, Miccoli R, Pucci L, Del Prato S. The metabolic syndrome. Pharmacological Research 2006;53:457-68. [DOI: 10.1016/j.phrs.2006.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
158 Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009;15:5141-8. [PMID: 19891012 DOI: 10.3748/wjg.15.5141] [Cited by in CrossRef: 111] [Cited by in F6Publishing: 96] [Article Influence: 10.1] [Reference Citation Analysis]
159 Cheng TO. Cardiovascular health, risks and diseases in contemporary China. International Journal of Cardiology 2011;152:285-94. [DOI: 10.1016/j.ijcard.2011.08.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
160 Yu D, Huang J, Hu D, Chen J, Cao J, Li J. Is an appropriate cutoff of hypertriglyceridemic waist designated for type 2 diabetes among Chinese adults? Clin Nutr 2010;29:192-8. [PMID: 20153095 DOI: 10.1016/j.clnu.2009.06.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
161 Libby P, Ridker PM. Inflammation and Atherothrombosis. Journal of the American College of Cardiology 2006;48:A33-46. [DOI: 10.1016/j.jacc.2006.08.011] [Cited by in Crossref: 121] [Cited by in F6Publishing: 66] [Article Influence: 8.1] [Reference Citation Analysis]
162 Mathur SK, Jain P, Mathur P. Microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications. J Obes 2011;2011:587495. [PMID: 21603273 DOI: 10.1155/2011/587495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
163 Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res 2012;3:204-11. [PMID: 22923938 DOI: 10.4103/0975-3583.98895] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 9.3] [Reference Citation Analysis]
164 Wilkinson L, Yi N, Mehta T, Judd S, Garvey WT. Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study. PLoS Med 2020;17:e1003232. [PMID: 32764746 DOI: 10.1371/journal.pmed.1003232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
165 Mercado CI, Yang Q, Ford ES, Gregg E, Valderrama AL. Gender- and race-specific metabolic score and cardiovascular disease mortality in adults: A structural equation modeling approach--United States, 1988-2006. Obesity (Silver Spring) 2015;23:1911-9. [PMID: 26308480 DOI: 10.1002/oby.21171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
166 Tompuri TT, Jääskeläinen J, Lindi V, Laaksonen DE, Eloranta AM, Viitasalo A, Laitinen T, Lakka TA. Adiposity Criteria in Assessing Increased Cardiometabolic Risk in Prepubertal Children. Front Endocrinol (Lausanne) 2019;10:410. [PMID: 31293520 DOI: 10.3389/fendo.2019.00410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
167 Lin WY, Yang WS, Lee LT, Chen CY, Liu CS, Lin CC, Huang KC. Insulin resistance, obesity, and metabolic syndrome among non-diabetic pre- and post-menopausal women in North Taiwan. Int J Obes (Lond) 2006;30:912-7. [PMID: 16432538 DOI: 10.1038/sj.ijo.0803240] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
168 Chatzi L, Plana E, Daraki V, Karakosta P, Alegkakis D, Tsatsanis C, Kafatos A, Koutis A, Kogevinas M. Metabolic Syndrome in Early Pregnancy and Risk of Preterm Birth. American Journal of Epidemiology 2009;170:829-36. [DOI: 10.1093/aje/kwp211] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 10.1] [Reference Citation Analysis]
169 Després JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006;38:52-63. [PMID: 16448989 DOI: 10.1080/07853890500383895] [Cited by in Crossref: 380] [Cited by in F6Publishing: 302] [Article Influence: 25.3] [Reference Citation Analysis]
170 Sharma R. Continuous Metabolic Syndrome Score in Children: How Useful is it? Indian J Pediatr 2019;86:881-2. [DOI: 10.1007/s12098-019-03047-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Cao RY, Zheng H, Redfearn D, Yang J. FNDC5: A novel player in metabolism and metabolic syndrome. Biochimie 2019;158:111-6. [PMID: 30611879 DOI: 10.1016/j.biochi.2019.01.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
172 Segura J, Banegas JR, García-donaire JA, Rodríguez-artalejo F, Cruz JJ, Praga M, Ruilope LM. Should Hypertension Guidelines Be Changed for Hypertensive Patients With the Metabolic Syndrome? J Clin Hypertension 2007;9:595-600. [DOI: 10.1111/j.1524-6175.2007.06522.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
173 Amini M, Janghorbani M. Comparison of metabolic syndrome with glucose measurement for prediction of type 2 diabetes: The Isfahan Diabetes Prevention Study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2009;3:84-9. [DOI: 10.1016/j.dsx.2009.02.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
174 Sumner AE, Zhou J, Doumatey A, Imoisili OE, Amoah A, Acheampong J, Oli J, Johnson T, Adebamowo C, Rotimi CN. Low HDL-Cholesterol with Normal Triglyceride Levels is the Most Common Lipid Pattern in West Africans and African Americans with Metabolic Syndrome: Implications for Cardiovascular Disease Prevention. CVD Prev Control 2010;5:75-80. [PMID: 21113431 DOI: 10.1016/j.cvdpc.2010.07.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
175 Netchitaïlo M, Destors M, Bosc C, Pépin JL, Tamisier R. [Obstructive sleep apnea syndrome. Diagnostic strategies in various clinical settings]. Presse Med 2017;46:404-12. [PMID: 28126505 DOI: 10.1016/j.lpm.2016.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Deedwania PC, Maki KC, Dicklin MR, Stone NJ, Ballantyne CM, Davidson MH. Application of Recent Definitions of the Metabolic Syndrome to Survey Data From the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II). J CardioMetab Syndrome 2006;1:295-300. [DOI: 10.1111/j.1559-4564.2006.05902.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
177 Bernardi S, Fabris B, Thomas M, Toffoli B, Tikellis C, Candido R, Catena C, Mulatero P, Barbone F, Radillo O. Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes. Mol Cell Endocrinol. 2014;394:13-20. [PMID: 24998520 DOI: 10.1016/j.mce.2014.06.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
178 Contaldo F, Santarpia L, Pasanisi F. The metabolic syndrome: A syndrome and not a disease. Nutrition 2010;26:1058. [DOI: 10.1016/j.nut.2010.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
179 Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Ono Y, Nishimura K, Okayama A, Miyamoto Y. A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: the Suita study. Atherosclerosis 2011;217:201-6. [PMID: 21481396 DOI: 10.1016/j.atherosclerosis.2011.03.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
180 Sidiropoulos PI, Karvounaris SA, Boumpas DT. Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Ther 2008;10:207. [PMID: 18492218 DOI: 10.1186/ar2397] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
181 Plaza-Diaz J, Gomez-Llorente C, Abadia-Molina F, Saez-Lara MJ, Campaña-Martin L, Muñoz-Quezada S, Romero F, Gil A, Fontana L. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats. PLoS One 2014;9:e98401. [PMID: 24852284 DOI: 10.1371/journal.pone.0098401] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
182 Sarafidis PA, Ruilope LM. Insulin resistance, microalbuminuria, and chronic kidney disease. Curr Hypertens Rep 2008;10:249-51. [PMID: 18625151 DOI: 10.1007/s11906-008-0046-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
183 Henderson M, Van Hulst A, von Oettingen JE, Benedetti A, Paradis G. Normal weight metabolically unhealthy phenotype in youth: Do definitions matter? Pediatr Diabetes 2019;20:143-51. [PMID: 30294842 DOI: 10.1111/pedi.12785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
184 Kressel G, Trunz B, Bub A, Hülsmann O, Wolters M, Lichtinghagen R, Stichtenoth DO, Hahn A. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis 2009;202:263-71. [DOI: 10.1016/j.atherosclerosis.2008.04.012] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
185 Cook S, Auinger P, Li C, Ford ES. Metabolic Syndrome Rates in United States Adolescents, from the National Health and Nutrition Examination Survey, 1999–2002. The Journal of Pediatrics 2008;152:165-170.e2. [DOI: 10.1016/j.jpeds.2007.06.004] [Cited by in Crossref: 225] [Cited by in F6Publishing: 191] [Article Influence: 17.3] [Reference Citation Analysis]
186 Franklin SS. Hypertension in the metabolic syndrome. Metab Syndr Relat Disord 2006;4:287-98. [PMID: 18370747 DOI: 10.1089/met.2006.4.287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
187 Zhou H, Guo Z, Yu L, Hu X, Xu B, Liu H, Wu M, Zhou Z. Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Diabetes Research and Clinical Practice 2010;90:319-25. [DOI: 10.1016/j.diabres.2010.09.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
188 Bayturan O, Tuzcu EM, Uno K, Lavoie AJ, Hu T, Shreevatsa A, Wolski K, Schoenhagen P, Kapadia S, Nissen SE, Nicholls SJ. Comparison of Rates of Progression of Coronary Atherosclerosis in Patients With Diabetes Mellitus Versus Those With the Metabolic Syndrome. The American Journal of Cardiology 2010;105:1735-9. [DOI: 10.1016/j.amjcard.2010.01.359] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
189 Hanefeld M, Pistrosch F, Bornstein SR, Birkenfeld AL. The metabolic vascular syndrome - guide to an individualized treatment. Rev Endocr Metab Disord 2016;17:5-17. [PMID: 26956847 DOI: 10.1007/s11154-016-9345-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
190 Mozaffary A, Bozorgmanesh M, Sheikholeslami F, Azizi F, Eskandari F, Hadaegh F. Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study. Eur J Clin Nutr 2014;68:853-8. [DOI: 10.1038/ejcn.2014.91] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
191 Talluri R, Shete S. An approach to estimate bidirectional mediation effects with application to body mass index and fasting glucose. Ann Hum Genet 2018;82:396-406. [PMID: 29993118 DOI: 10.1111/ahg.12261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
192 de Almeida KM, Moreira CL, Lafer B. Metabolic syndrome and bipolar disorder: what should psychiatrists know? CNS Neurosci Ther 2012;18:160-6. [PMID: 22070636 DOI: 10.1111/j.1755-5949.2011.00240.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
193 Hong Y, Jin X, Mo J, Lin HM, Duan Y, Pu M, Wolbrette DL, Liao D. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study. J Intern Med 2007;262:113-22. [PMID: 17598819 DOI: 10.1111/j.1365-2796.2007.01781.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
194 Deboer MD. Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Rev Endocrinol Metab. 2011;6:279-289. [PMID: 21643518 DOI: 10.1586/eem.11.17] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
195 Chien KL, Lee BC, Hsu HC, Lin HJ, Chen MF, Lee YT. Prevalence, agreement and classification of various metabolic syndrome criteria among ethnic Chinese: a report on the hospital-based health diagnosis of the adult population. Atherosclerosis 2008;196:764-71. [PMID: 17291512 DOI: 10.1016/j.atherosclerosis.2007.01.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
196 Yamada C, Moriyama K, Takahashi E. Association between insulin resistance and metabolic syndrome risk factors in Japanese. J Diabetes Investig 2012;3:185-90. [PMID: 24843564 DOI: 10.1111/j.2040-1124.2011.00162.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
197 Gingras V, Leroux C, Fortin A, Legault L, Rabasa-Lhoret R. Predictors of cardiovascular risk among patients with type 1 diabetes: A critical analysis of the metabolic syndrome and its components. Diabetes Metab 2017;43:217-22. [PMID: 28139436 DOI: 10.1016/j.diabet.2016.10.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
198 Reinehr T. Calculating cardiac risk in obese adolescents before and after onset of lifestyle intervention. Expert Rev Cardiovasc Ther 2013;11:297-306. [PMID: 23469910 DOI: 10.1586/erc.13.6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
199 Therond P. Catabolism of lipoproteins and metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2009;12:366-371. [PMID: 19474714 DOI: 10.1097/mco.0b013e32832c5a12] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
200 Kwon CH, Kim BJ, Kim BS, Kang JH. Low-density lipoprotein cholesterol to apolipoprotein B ratio is independently associated with metabolic syndrome in Korean men. Metabolism 2011;60:1136-41. [DOI: 10.1016/j.metabol.2010.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
201 Luppino FS, van Reedt Dortland AKB, Wardenaar KJ, Bouvy PF, Giltay EJ, Zitman FG, Penninx BWJH. Symptom Dimensions of Depression and Anxiety and the Metabolic Syndrome. Psychosomatic Medicine 2011;73:257-64. [DOI: 10.1097/psy.0b013e31820a59c0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
202 Hoffmann MS, Brunoni AR, Stringaris A, Viana MC, Lotufo PA, Benseñor IM, Salum GA. Common and specific aspects of anxiety and depression and the metabolic syndrome. J Psychiatr Res 2021;137:117-25. [PMID: 33677215 DOI: 10.1016/j.jpsychires.2021.02.052] [Reference Citation Analysis]
203 Lau SL, Muir C, Assur Y, Beach R, Tran B, Bartrop R, Mclean M, Caetano D. Predicting Weight Gain in Patients Treated With Clozapine: The Role of Sex, Body Mass Index, and Smoking. Journal of Clinical Psychopharmacology 2016;36:120-4. [DOI: 10.1097/jcp.0000000000000476] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
204 Martins D, Tareen N, Ogedegbe G, Pan D, Norris K. The relative risk of cardiovascular death among racial and ethnic minorities with metabolic syndrome: data from the NHANES-II mortality follow-up. J Natl Med Assoc 2008;100:565-71. [PMID: 18507210 DOI: 10.1016/s0027-9684(15)31304-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
205 Day C. Metabolic syndrome, or What you will: definitions and epidemiology. Diabetes and Vascular Disease Research 2007;4:32-8. [DOI: 10.3132/dvdr.2007.003] [Cited by in Crossref: 176] [Cited by in F6Publishing: 138] [Article Influence: 35.2] [Reference Citation Analysis]
206 Olgar Y, Tuncay E, Billur D, Durak A, Ozdemir S, Turan B. Ticagrelor reverses the mitochondrial dysfunction through preventing accumulated autophagosomes-dependent apoptosis and ER stress in insulin-resistant H9c2 myocytes. Mol Cell Biochem 2020;469:97-107. [PMID: 32301059 DOI: 10.1007/s11010-020-03731-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
207 Seo JA, Song SW, Han K, Lee KJ, Kim HN. The associations between serum zinc levels and metabolic syndrome in the Korean population: findings from the 2010 Korean National Health and Nutrition Examination Survey. PLoS One 2014;9:e105990. [PMID: 25153887 DOI: 10.1371/journal.pone.0105990] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
208 Reaven GM. Metabolic Syndrome. In: Hansen BC, Bray GA, editors. The Metabolic Syndrome. Totowa: Humana Press; 2008. pp. 11-36. [DOI: 10.1007/978-1-60327-116-5_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
209 Kuzuya M, Ando F, Iguchi A, Shimokata H. Age-specific change of prevalence of metabolic syndrome: Longitudinal observation of large Japanese cohort. Atherosclerosis 2007;191:305-12. [DOI: 10.1016/j.atherosclerosis.2006.05.043] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
210 Tveit RL, Lehmann S, Bjorvatn B. Prevalence of several somatic diseases depends on the presence and severity of obstructive sleep apnea. PLoS One 2018;13:e0192671. [PMID: 29474482 DOI: 10.1371/journal.pone.0192671] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
211 Fisher M. Cardiometabolic disease: the new challenge? Pract Diab Int 2006;23:95-7. [DOI: 10.1002/pdi.909] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
212 Gatidis S, Schlett CL, Notohamiprodjo M, Bamberg F. Imaging-based characterization of cardiometabolic phenotypes focusing on whole-body MRI--an approach to disease prevention and personalized treatment. Br J Radiol 2016;89:20150829. [PMID: 26780657 DOI: 10.1259/bjr.20150829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
213 Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Santamato A, Ranieri M, Fiore P, Vendemiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V. Vascular risk factors, alcohol intake, and cognitive decline. J Nutr Health Aging 2008;12:376-81. [PMID: 18548174 DOI: 10.1007/BF02982669] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
214 Oda E, Kawai R. A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population. Environ Health Prev Med 2009;14:284-91. [PMID: 19626393 DOI: 10.1007/s12199-009-0098-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
215 Pasquali R. The hypothalamic-pituitary-adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects. Ann N Y Acad Sci. 2012;1264:20-35. [PMID: 22612409 DOI: 10.1111/j.1749-6632.2012.06569.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
216 Dimitrov BD, Bahchevanov KM, Atanassova PA, Mitkov MD, Massaldjieva RI, Chompalov KA, Hadzhipetrov GK. Metabolic syndrome severity score: range and associations with cardiovascular risk factors. Arch Med Sci Atheroscler Dis 2016;1:e90-7. [PMID: 28905027 DOI: 10.5114/amsad.2016.62137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
217 de Almeida MDV, Pinhao S, Stewart-knox B, Parr HJ, Gibney MJ. A six-country European survey on consumer attitudes to the metabolic syndrome, genetics in nutrition and potential agro-food technologies: questionnaire design methodology. Nutr Bulletin 2006;31:138-44. [DOI: 10.1111/j.1467-3010.2006.00550.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
218 Annaloro C, Airaghi L, Saporiti G, Onida F, Cortelezzi A, Deliliers GL. Metabolic syndrome in patients with hematological diseases. Expert Review of Hematology 2014;5:439-58. [DOI: 10.1586/ehm.12.35] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
219 Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 2009;181:1998-2006; discussion 2007-8. [PMID: 19286225 DOI: 10.1016/j.juro.2009.01.047] [Cited by in Crossref: 160] [Cited by in F6Publishing: 113] [Article Influence: 13.3] [Reference Citation Analysis]
220 Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Després JP, Ndumele CE, Vijayaraghavan K, Handelsman Y, Puckrein GA, Araneta MR, Blum QK, Collins KK, Cook S, Dhurandhar NV, Dixon DL, Egan BM, Ferdinand DP, Herman LM, Hessen SE, Jacobson TA, Pate RR, Ratner RE, Brinton EA, Forker AD, Ritzenthaler LL, Grundy SM. The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. J Am Coll Cardiol 2015;66:1050-67. [PMID: 26314534 DOI: 10.1016/j.jacc.2015.06.1328] [Cited by in Crossref: 133] [Cited by in F6Publishing: 101] [Article Influence: 22.2] [Reference Citation Analysis]
221 Ragbourne SC, Crook MA. Metabolic Syndrome in Long-Term Survivors of Hematopoietic Stem-Cell Transplantation. Clin Lymphoma Myeloma Leuk 2017;17:340-6. [PMID: 28622958 DOI: 10.1016/j.clml.2017.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
222 Stocks T, Bjørge T, Ulmer H, Manjer J, Häggström C, Nagel G, Engeland A, Johansen D, Hallmans G, Selmer R, Concin H, Tretli S, Jonsson H, Stattin P. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol 2015;44:1353-63. [PMID: 25652574 DOI: 10.1093/ije/dyv001] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 11.5] [Reference Citation Analysis]
223 Saydah S, Ballard-Barbash R, Potischman N. Association of metabolic syndrome with insulin-like growth factors among adults in the US. Cancer Causes Control 2009;20:1309-16. [PMID: 19415508 DOI: 10.1007/s10552-009-9351-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
224 Kim NH, Cho HJ, Kim YJ, Cho MJ, Choi HY, Eun CR, Kim J, Yang SJ, Yoo HJ, Kim HY, Seo JA, Kim SG, Baik SH, Choi DS, Choi KM. Combined Effect of High-Normal Blood Pressure and Low HDL Cholesterol on Mortality in an Elderly Korean Population: The South-West Seoul (SWS) Study. American Journal of Hypertension 2011;24:918-23. [DOI: 10.1038/ajh.2011.78] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
225 Pischon T, Hu FB, Rexrode KM, Girman CJ, Manson JE, Rimm EB. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 2008;197:392-9. [PMID: 17681508 DOI: 10.1016/j.atherosclerosis.2007.06.022] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
226 Bauman WA. The potential metabolic consequences of cerebral palsy: inferences from the general population and persons with spinal cord injury. Dev Med Child Neurol 2009;51 Suppl 4:64-78. [PMID: 19740212 DOI: 10.1111/j.1469-8749.2009.03430.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
227 Oda E, Kawai R. Changes in body weight are significantly associated with changes in fasting plasma glucose and HDL cholesterol in Japanese men without abdominal obesity (waist circumference < 85 cm). Acta Diabetol 2011;48:143-8. [DOI: 10.1007/s00592-010-0238-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
228 Rizzo M, Pernice V, Frasheri A, Di Lorenzo G, Rini GB, Spinas GA, Berneis K. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrinol (Oxf) 2009;70:870-5. [PMID: 18771560 DOI: 10.1111/j.1365-2265.2008.03407.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
229 Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, Bernal-mizrachi C, Muslin AJ, Kastan MB, Semenkovich CF. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metabolism 2006;4:377-89. [DOI: 10.1016/j.cmet.2006.10.002] [Cited by in Crossref: 169] [Cited by in F6Publishing: 155] [Article Influence: 11.3] [Reference Citation Analysis]
230 Nagahori M, Hyun SB, Totsuka T, Okamoto R, Kuwahara E, Takebayashi T, Naganuma M, Watanabe M. Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population. J Gastroenterol. 2010;45:1008-1013. [PMID: 20414788 DOI: 10.1007/s00535-010-0247-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
231 Körner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W. New Predictors of the Metabolic Syndrome in Children—Role of Adipocytokines. Pediatr Res 2007;61:640-5. [DOI: 10.1203/01.pdr.0000262638.48304.ef] [Cited by in Crossref: 110] [Cited by in F6Publishing: 85] [Article Influence: 7.9] [Reference Citation Analysis]
232 Bays HE, Fox KM, Grandy S; SHIELD Study Group. Anthropometric measurements and diabetes mellitus: clues to the "pathogenic" and "protective" potential of adipose tissue. Metab Syndr Relat Disord 2010;8:307-15. [PMID: 20235743 DOI: 10.1089/met.2009.0089] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
233 Agyemang C, van Valkengoed IG, van den Born BJ, Bhopal R, Stronks K. Heterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations: Sexual heterogeneity in the metabolic syndrome. Diabetic Medicine 2012;29:1159-64. [DOI: 10.1111/j.1464-5491.2012.03616.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
234 Zhu S, McClure LA, Lau H, Romero JR, White CL, Babikian V, Nguyen T, Benavente OR, Kase CS, Pikula A. Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes. Neurology. 2015;85:935-941. [PMID: 26296518 DOI: 10.1212/wnl.0000000000001933] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
235 Rask Larsen J, Dima L, Correll CU, Manu P. The pharmacological management of metabolic syndrome. Expert Rev Clin Pharmacol. 2018;11:397-410. [PMID: 29345505 DOI: 10.1080/17512433.2018.1429910] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 12.3] [Reference Citation Analysis]
236 Averbeck MA, Colares C, de Lira GH, Selbach T, Rhoden EL. Evaluation of endothelial function with brachial artery ultrasound in men with or without erectile dysfunction and classified as intermediate risk according to the Framingham Score. J Sex Med 2012;9:849-56. [PMID: 22239818 DOI: 10.1111/j.1743-6109.2011.02591.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
237 Moebus S, Balijepalli C, Lösch C, Göres L, von Stritzky B, Bramlage P, Wasem J, Jöckel KH. Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study. Cardiovasc Diabetol 2010;9:34. [PMID: 20696055 DOI: 10.1186/1475-2840-9-34] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
238 Edwards CM, Cusi K. Prediabetes: A Worldwide Epidemic. Endocrinol Metab Clin North Am 2016;45:751-64. [PMID: 27823603 DOI: 10.1016/j.ecl.2016.06.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
239 Nasrallah HA. Metabolic findings from the CATIE trial and their relation to tolerability. CNS Spectr 2006;11:32-9. [PMID: 16816798 DOI: 10.1017/s1092852900026663] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
240 Koshiyama H, Honjo S, Hamamoto Y, Ikeda H, Wada Y. Drugs share antidiabetic and antiatherosclerotic actions through “the common soil”. Medical Hypotheses 2006;66:473-5. [DOI: 10.1016/j.mehy.2005.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
241 Franch-Nadal J, Caballeria L, Mata-Cases M, Mauricio D, Giraldez-García C, Mancera J, Goday A, Mundet-Tudurí X, Regidor E; PREDAPS Study Group. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. PLoS One 2018;13:e0198327. [PMID: 29856820 DOI: 10.1371/journal.pone.0198327] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
242 Corona G, Mannucci E, Forti G, Maggi M. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. International Journal of Andrology 2009;32:587-98. [DOI: 10.1111/j.1365-2605.2008.00951.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 127] [Article Influence: 13.3] [Reference Citation Analysis]
243 Wassink AM, Olijhoek JK, Visseren FL. The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest 2007;37:8-17. [PMID: 17181562 DOI: 10.1111/j.1365-2362.2007.01755.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
244 Kim Y, Conners RT, Hart PD, Kang YS, Kang M. Association of physical activity and body mass index with metabolic syndrome among U.S. adolescents with disabilities. Disabil Health J 2013;6:253-9. [PMID: 23769485 DOI: 10.1016/j.dhjo.2013.01.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
245 Townsend RR, Anderson AH, Chen J, Gadebegku CA, Feldman HI, Fink JC, Go AS, Joffe M, Nessel LA, Ojo A. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol. 2011;33:477-484. [PMID: 21525746 DOI: 10.1159/000327618] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
246 Dragsbæk K, Neergaard JS, Laursen JM, Hansen HB, Christiansen C, Beck-Nielsen H, Karsdal MA, Brix S, Henriksen K. Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: Challenging the current definition. Medicine (Baltimore) 2016;95:e4806. [PMID: 27603394 DOI: 10.1097/MD.0000000000004806] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
247 Corona G, Forti G, Maggi M. Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome. The Aging Male 2009;11:193-9. [DOI: 10.1080/13685530802468497] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
248 Faramawi MF, Sall M, Abdul Kareem MY. The Association of the Metabolic Syndrome with T-wave Axis Deviation in NHANES III. Annals of Epidemiology 2008;18:702-7. [DOI: 10.1016/j.annepidem.2008.06.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
249 Stenholm S, Koster A, Alley DE, Visser M, Maggio M, Harris TB, Egan JM, Bandinelli S, Guralnik JM, Ferrucci L. Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study. Clin Endocrinol (Oxf) 2010;73:55-65. [PMID: 19878507 DOI: 10.1111/j.1365-2265.2009.03742.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
250 Özkalaycı F, Gülmez Ö, Uğur-Altun B, Pandi-Perumal SR, Altun A. The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox. Balkan Med J 2018;35:225-32. [PMID: 29687784 DOI: 10.4274/balkanmedj.2018.0579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
251 Yu Z, Ning Y, Yu H, Tang N. A HPLC-Q-TOF-MS-based urinary metabolomic approach to identification of potential biomarkers of metabolic syndrome. J Huazhong Univ Sci Technol [Med Sci ] 2014;34:276-83. [DOI: 10.1007/s11596-014-1271-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
252 Liauw SS, McIntyre RS. Atypical antipsychotic tolerability and switching strategies in bipolar disorder. Expert Opin Pharmacother 2010;11:2827-37. [PMID: 20726821 DOI: 10.1517/14656566.2010.510835] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
253 Chiang PH, Liu CL, Lin MH, Peng LN, Chen LK, Chen JD, Hou SM. Survival benefits of metabolic syndrome among older men aged 75 years and over in Taiwan. J Nutr Health Aging 2012;16:520-4. [PMID: 22659989 DOI: 10.1007/s12603-011-0344-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
254 Laakso M, Kovanen PT. Metabolic syndrome: To be or not to be? Annals of Medicine 2009;38:32-3. [DOI: 10.1080/07853890500457558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
255 Pallava A, Chadda RK, Sood M, Lakshmy R. Metabolic syndrome in schizophrenia: A comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India. Nordic Journal of Psychiatry 2012;66:215-21. [DOI: 10.3109/08039488.2011.621977] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
256 Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629-636. [PMID: 18174459 DOI: 10.1161/atvbaha.107.151092] [Cited by in Crossref: 860] [Cited by in F6Publishing: 365] [Article Influence: 66.2] [Reference Citation Analysis]
257 Bordeaux BC, Qayyum R, Yanek LR, Vaidya D, Becker LC, Faraday N, Becker DM. Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin. Preventive Cardiology 2010;13:56-62. [DOI: 10.1111/j.1751-7141.2009.00058.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
258 Sobel BE. The metabolic syndrome vis-??-vis syndrome of insulin resistance: the perfect squall: . Coronary Artery Disease 2005;16:461-3. [DOI: 10.1097/00019501-200512000-00001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
259 Huang TT, Ball GD, Franks PW. Metabolic syndrome in youth: current issues and challenges. Appl Physiol Nutr Metab 2007;32:13-22. [DOI: 10.1139/h06-094] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
260 Carroll SJ, Paquet C, Howard NJ, Adams RJ, Taylor AW, Daniel M. Validation of continuous clinical indices of cardiometabolic risk in a cohort of Australian adults. BMC Cardiovasc Disord 2014;14:27. [PMID: 24571233 DOI: 10.1186/1471-2261-14-27] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
261 Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115:114-126. [PMID: 17192512 DOI: 10.1161/circulationaha.106.179294] [Cited by in Crossref: 482] [Cited by in F6Publishing: 184] [Article Influence: 32.1] [Reference Citation Analysis]
262 Nagel G, Stocks T, Späth D, Hjartåker A, Lindkvist B, Hallmans G, Jonsson H, Bjørge T, Manjer J, Häggström C, Engeland A, Ulmer H, Selmer R, Concin H, Stattin P, Schlenk RF. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Ann Hematol 2012;91:1519-31. [PMID: 22588328 DOI: 10.1007/s00277-012-1489-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
263 Paras E, Mancini GJ, Lear SA. The relationship of three common definitions of the metabolic syndrome with sub-clinical carotid atherosclerosis. Atherosclerosis 2008;198:228-36. [DOI: 10.1016/j.atherosclerosis.2007.09.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
264 Verkest KR. Is the metabolic syndrome a useful clinical concept in dogs? A review of the evidence. The Veterinary Journal 2014;199:24-30. [DOI: 10.1016/j.tvjl.2013.09.057] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
265 Benito P, Caballero J, Moreno J, Gutiérrez-Alcántara C, Muñoz C, Rojo G, Garcia S, Soriguer FC. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 2006;25:581-7. [PMID: 16701922 DOI: 10.1016/j.clnu.2005.12.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
266 Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer? Am J Pathol 2006;169:1505-22. [PMID: 17071576 DOI: 10.2353/ajpath.2006.051090] [Cited by in Crossref: 277] [Cited by in F6Publishing: 238] [Article Influence: 18.5] [Reference Citation Analysis]
267 Ford ES, Schulze MB, Pischon T, Bergmann MM, Joost HG, Boeing H. Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Cardiovasc Diabetol 2008;7:35. [PMID: 19077281 DOI: 10.1186/1475-2840-7-35] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
268 Catenacci VA, Hill JO, Wyatt HR. The obesity epidemic. Clin Chest Med 2009;30:415-44, vii. [PMID: 19700042 DOI: 10.1016/j.ccm.2009.05.001] [Cited by in Crossref: 112] [Cited by in F6Publishing: 94] [Article Influence: 10.2] [Reference Citation Analysis]
269 Mul G, Cusimano P, Cerasola G. The metabolic syndromearterial stiffness relationship in patients with ischaemic stroke: role of inflammation. European Journal of Neurology 2008;15:759-61. [DOI: 10.1111/j.1468-1331.2008.02205.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
270 Gemignani F. Idiopathic polyneuropathy and pre-diabetes: a fat wedding? European Journal of Neurology 2008;15:757-8. [DOI: 10.1111/j.1468-1331.2008.02198.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
271 Smits MM, Woudstra P, Utzschneider KM, Tong J, Gerchman F, Faulenbach M, Carr DB, Aston-Mourney K, Chait A, Knopp RH, Meigs JB, Boyko EJ, Kahn SE. Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis. Ann Epidemiol 2013;23:415-21. [PMID: 23535025 DOI: 10.1016/j.annepidem.2013.03.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
272 Ejtahed HS, Qorbani M, Motlagh ME, Angoorani P, Hasani-Ranjbar S, Ziaodini H, Taheri M, Ahadi Z, Beshtar S, Aminaee T, Heshmat R, Kelishadi R. Association of anthropometric indices with continuous metabolic syndrome in children and adolescents: the CASPIAN-V study. Eat Weight Disord 2018;23:597-604. [PMID: 29094277 DOI: 10.1007/s40519-017-0455-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
273 Batallés SM, Villavicencio RL, Quaranta A, Burgos L, Trezzo S, Staffieri R, Pezzotto SM. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies]. Rev Esp Med Nucl Imagen Mol 2013;32:26-32. [PMID: 23177341 DOI: 10.1016/j.remn.2012.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
274 Blaum CS, West NA, Haan MN. Is the metabolic syndrome, with or without diabetes, associated with progressive disability in older Mexican Americans? J Gerontol A Biol Sci Med Sci 2007;62:766-73. [PMID: 17634325 DOI: 10.1093/gerona/62.7.766] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
275 Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D'Agostino RB, Gaziano JM, Vasan RS. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 2007;116:480-8. [PMID: 17646581 DOI: 10.1161/CIRCULATIONAHA.107.689935] [Cited by in Crossref: 587] [Cited by in F6Publishing: 280] [Article Influence: 41.9] [Reference Citation Analysis]
276 Sun SS, Sabo R, Arslanian S, Wu R, Sabo C. Age variation and sexual dimorphism in the sixteen diagnostic clusters of risk factors for the metabolic syndrome. Z Gesundh Wiss 2012;20:487-97. [PMID: 23002329 DOI: 10.1007/s10389-012-0490-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
277 Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008;196:696-703. [PMID: 17254586 DOI: 10.1016/j.atherosclerosis.2006.12.018] [Cited by in Crossref: 155] [Cited by in F6Publishing: 143] [Article Influence: 11.1] [Reference Citation Analysis]
278 Ionescu-tirgoviste C, Ioacara S, Guja C, Sabau S, Lichiardopol R, Mihai A, Apetrei E. A pathophysiological approach to metabolic syndrome using factor analysis in an adult Romanian population. Archives of Physiology and Biochemistry 2008;112:182-8. [DOI: 10.1080/13813450600976374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
279 Benetos A, Thomas F, Pannier B, Bean K, Jégo B, Guize L. All-Cause and Cardiovascular Mortality Using the Different Definitions of Metabolic Syndrome. The American Journal of Cardiology 2008;102:188-91. [DOI: 10.1016/j.amjcard.2008.03.037] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
280 Plaza-Díaz J, Robles-Sánchez C, Abadía-Molina F, Sáez-Lara MJ, Vilchez-Padial LM, Gil Á, Gómez-Llorente C, Fontana L. Gene expression profiling in the intestinal mucosa of obese rats administered probiotic bacteria. Sci Data 2017;4:170186. [PMID: 29231922 DOI: 10.1038/sdata.2017.186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
281 Saravia G, Civeira F, Hurtado-Roca Y, Andres E, Leon M, Pocovi M, Ordovas J, Guallar E, Fernandez-Ortiz A, Casasnovas JA, Laclaustra M. Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline. PLoS One 2015;10:e0132244. [PMID: 26241903 DOI: 10.1371/journal.pone.0132244] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
282 Chen S, Henderson A, Petriello MC, Romano KA, Gearing M, Miao J, Schell M, Sandoval-Espinola WJ, Tao J, Sha B, Graham M, Crooke R, Kleinridders A, Balskus EP, Rey FE, Morris AJ, Biddinger SB. Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction. Cell Metab 2019; 30: 1141-1151. e5. [PMID: 31543404 DOI: 10.1016/j.cmet.2019.08.021] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 29.5] [Reference Citation Analysis]
283 Kakafika AI, Mikhailidis DP, Karagiannis A, Athyros VG. The Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome. The Journal of Clinical Pharmacology 2007;47:642-52. [DOI: 10.1177/0091270007299358] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
284 Hanouneh IA, Feldstein AE, Lopez R, Yerian L, Pillai A, Zein CO, Zein NN. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2008;6:584-589. [PMID: 18455698 DOI: 10.1016/j.cgh.2008.02.034] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
285 Gil-núñez A. The Metabolic Syndrome and Cerebrovascular Disease: Suspicion and Evidence. Cerebrovasc Dis 2007;24:64-75. [DOI: 10.1159/000107380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
286 Serra A, Granada M, Romero R, Bayés B, Cantón A, Bonet J, Rull M, Alastrue A, Formiguera X. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clinical Nutrition 2006;25:400-8. [DOI: 10.1016/j.clnu.2005.11.014] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
287 Mente A, Yusuf S, Islam S, Mcqueen MJ, Tanomsup S, Onen CL, Rangarajan S, Gerstein HC, Anand SS. Metabolic Syndrome and Risk of Acute Myocardial Infarction. Journal of the American College of Cardiology 2010;55:2390-8. [DOI: 10.1016/j.jacc.2009.12.053] [Cited by in Crossref: 141] [Cited by in F6Publishing: 102] [Article Influence: 12.8] [Reference Citation Analysis]
288 Sullivan VK. Prevention and treatment of the metabolic syndrome with lifestyle intervention: where do we start? J Am Diet Assoc 2006;106:668-71. [PMID: 16647323 DOI: 10.1016/j.jada.2006.03.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
289 Steemburgo T, Dall'alba V, Almeida JC, Zelmanovitz T, Gross JL, de Azevedo MJ. Intake of soluble fibers has a protective role for the presence of metabolic syndrome in patients with type 2 diabetes. Eur J Clin Nutr 2009;63:127-33. [DOI: 10.1038/sj.ejcn.1602902] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
290 Gyawali P, Richards RS, Uba Nwose E. Erythrocyte morphology in metabolic syndrome. Expert Review of Hematology 2014;5:523-31. [DOI: 10.1586/ehm.12.47] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
291 Pajunen P, Kotronen A, Korpi-Hyövälti E, Keinänen-Kiukaanniemi S, Oksa H, Niskanen L, Saaristo T, Saltevo JT, Sundvall J, Vanhala M. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health. 2011;11:754. [PMID: 21962038 DOI: 10.1186/1471-2458-11-754] [Cited by in Crossref: 99] [Cited by in F6Publishing: 82] [Article Influence: 9.9] [Reference Citation Analysis]
292 Okosun IS, Boltri JM, Lyn R, Davis-smith M. Continuous Metabolic Syndrome Risk Score, Body Mass Index Percentile, and Leisure Time Physical Activity in American Children. The Journal of Clinical Hypertension 2010;12:636-44. [DOI: 10.1111/j.1751-7176.2010.00338.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
293 Sinaiko AR, Caprio S. Insulin resistance. J Pediatr 2012;161:11-5. [PMID: 22336575 DOI: 10.1016/j.jpeds.2012.01.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
294 Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V, Conti N, Tomolillo C, Deferrari G, Pontremoli R. Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. J Hum Hypertens 2007;21:802-7. [DOI: 10.1038/sj.jhh.1002240] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
295 Morote J, Gómez-Caamaño A, Alvarez-Ossorio JL, Pesqueira D, Tabernero A, Gómez Veiga F, Lorente JA, Porras M, Lobato JJ, Ribal MJ, Planas J; ANAMET Investigators Group. The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy. J Urol 2015;193:1963-9. [PMID: 25541340 DOI: 10.1016/j.juro.2014.12.086] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
296 Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 2008;7:125-34. [PMID: 18249172 DOI: 10.1016/j.cmet.2007.11.013] [Cited by in Crossref: 322] [Cited by in F6Publishing: 285] [Article Influence: 24.8] [Reference Citation Analysis]
297 Reinehr T, de Sousa G, Toschke AM, Andler W. Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child 2007;92:1067-72. [PMID: 17301109 DOI: 10.1136/adc.2006.104588] [Cited by in Crossref: 96] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
298 Vittone F, Chait A, Morse JS, Fish B, Brown BG, Zhao XQ. Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). J Clin Lipidol 2007;1:203-10. [PMID: 18591993 DOI: 10.1016/j.jacl.2007.05.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
299 Lonardo A, Leoni S, Alswat KA, Fouad Y. History of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2020;21:E5888. [PMID: 32824337 DOI: 10.3390/ijms21165888] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
300 Dueregger A, Heidegger I, Ofer P, Perktold B, Ramoner R, Klocker H, Eder IE. The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment. Nutrients 2014;6:4491-519. [PMID: 25338271 DOI: 10.3390/nu6104491] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
301 McPartland JM. Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship. PLoS One 2009;4:e5092. [PMID: 19333392 DOI: 10.1371/journal.pone.0005092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
302 Kraja AT, Chasman DI, North KE, Reiner AP, Yanek LR, Kilpeläinen TO, Smith JA, Dehghan A, Dupuis J, Johnson AD, Feitosa MF, Tekola-Ayele F, Chu AY, Nolte IM, Dastani Z, Morris A, Pendergrass SA, Sun YV, Ritchie MD, Vaez A, Lin H, Ligthart S, Marullo L, Rohde R, Shao Y, Ziegler MA, Im HK, Schnabel RB, Jørgensen T, Jørgensen ME, Hansen T, Pedersen O, Stolk RP, Snieder H, Hofman A, Uitterlinden AG, Franco OH, Ikram MA, Richards JB, Rotimi C, Wilson JG, Lange L, Ganesh SK, Nalls M, Rasmussen-Torvik LJ, Pankow JS, Coresh J, Tang W, Linda Kao WH, Boerwinkle E, Morrison AC, Ridker PM, Becker DM, Rotter JI, Kardia SL, Loos RJ, Larson MG, Hsu YH, Province MA, Tracy R, Voight BF, Vaidya D, O'Donnell CJ, Benjamin EJ, Alizadeh BZ, Prokopenko I, Meigs JB, Borecki IB; Cross Consortia Pleiotropy Group., Cohorts for Heart and., Aging Research in Genetic Epidemiology., Genetic Investigation of Anthropometric Traits Consortium., Global Lipids Genetics Consortium., Meta-Analyses of Glucose., Insulin-related traits Consortium., Global BPgen Consortium., ADIPOGen Consortium., Women's Genome Health Study., Howard University Family Study. Pleiotropic genes for metabolic syndrome and inflammation. Mol Genet Metab 2014;112:317-38. [PMID: 24981077 DOI: 10.1016/j.ymgme.2014.04.007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 10.6] [Reference Citation Analysis]
303 Costa JA, Rodilla E, Cardona J, González C, Pascual JM. Síndrome metabólico y complicaciones cardiovasculares en el paciente hipertenso. Medicina Clínica 2012;139:150-6. [DOI: 10.1016/j.medcli.2011.05.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
304 Holvoet P, De Keyzer D, Jacobs DR Jr. Oxidized LDL and the metabolic syndrome. Future Lipidol 2008;3:637-49. [PMID: 19802339 DOI: 10.2217/17460875.3.6.637] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
305 Azhar S, Kelley G. PPARα: its role in the human metabolic syndrome. Future Lipidology 2007;2:31-53. [DOI: 10.2217/17460875.2.1.31] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
306 Borges R, Temido P, Sousa L, Azinhais P, Conceição P, Pereira B, Leão R, Retroz E, Brandão Á, Cristo L, Sobral F. Metabolic Syndrome and Sexual (Dys)function. The Journal of Sexual Medicine 2009;6:2958-75. [DOI: 10.1111/j.1743-6109.2009.01412.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
307 Carroll SJ, Niyonsenga T, Coffee NT, Taylor AW, Daniel M. Does Physical Activity Mediate the Associations Between Local-Area Descriptive Norms, Built Environment Walkability, and Glycosylated Hemoglobin? Int J Environ Res Public Health 2017;14:E953. [PMID: 28832552 DOI: 10.3390/ijerph14090953] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
308 Meriño-Ibarra E, Cenarro A, Martín P, García-Otín AL, Goicoechea J, Guallar A, Calvo L, Civeira F. [Sensitivity and specificity of metabolic syndrome criteria for insulin resistance diagnosis in Spanish population]. Med Clin (Barc) 2007;128:168-71. [PMID: 17298777 DOI: 10.1157/13098390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
309 Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006;5:22. [PMID: 17078884 DOI: 10.1186/1475-2840-5-22] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 6.8] [Reference Citation Analysis]
310 Grundy SM. Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds. Journal of the American College of Cardiology 2006;47:1093-100. [DOI: 10.1016/j.jacc.2005.11.046] [Cited by in Crossref: 388] [Cited by in F6Publishing: 294] [Article Influence: 25.9] [Reference Citation Analysis]
311 Oda E. Historical perspectives of the metabolic syndrome. Clin Dermatol 2018;36:3-8. [PMID: 29241750 DOI: 10.1016/j.clindermatol.2017.09.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
312 Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Forti G, Maggi M. Low Levels of Androgens in Men with Erectile Dysfunction and Obesity. The Journal of Sexual Medicine 2008;5:2454-63. [DOI: 10.1111/j.1743-6109.2008.00856.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
313 Alshkri M, Elmehdawi R. Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi-Libya: A pilot study. Libyan Journal of Medicine 2016;3:177-80. [DOI: 10.3402/ljm.v3i4.4789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
314 Gimeno-Orna JA, Molinero-Herguedas E, Lou-Arnal LM, Boned-Juliani B, Labrador-Fuster T, Guiu-Campos M. [Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome]. Rev Esp Cardiol. 2007;60:1202-1205. [PMID: 17996182 DOI: 10.1016/s1885-5857(08)60059-6] [Reference Citation Analysis]
315 Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, Kraemer WJ, Bibus DM, Fernandez ML, Feinman RD. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009;44:297-309. [PMID: 19082851 DOI: 10.1007/s11745-008-3274-2] [Cited by in Crossref: 207] [Cited by in F6Publishing: 178] [Article Influence: 15.9] [Reference Citation Analysis]
316 Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte Ad, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N. Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study. Diabetes Care 2009;32:474-80. [PMID: 19056612 DOI: 10.2337/dc08-1394] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
317 Tian S, Dong W, Chan KL, Leng X, Bedford LE, Liu J. Screening for chronic conditions with reproductive factors using a machine learning based approach. Sci Rep 2020;10:2848. [PMID: 32071372 DOI: 10.1038/s41598-020-59825-3] [Reference Citation Analysis]
318 Fadini GP, Agostini C, Boscaro E, Avogaro A. Mechanisms and significance of progenitor cell reduction in the metabolic syndrome. Metab Syndr Relat Disord 2009;7:5-10. [PMID: 19183074 DOI: 10.1089/met.2008.0067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
319 Marques-Vidal P, Bastardot F, von Känel R, Paccaud F, Preisig M, Waeber G, Vollenweider P. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf) 2013;78:232-41. [PMID: 22409372 DOI: 10.1111/j.1365-2265.2012.04384.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
320 Guerra F, Mancinelli L, Angelini L, Fortunati M, Rappelli A, Dessì-Fulgheri P, Sarzani R. The association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients. PLoS One 2011;6:e16630. [PMID: 21304952 DOI: 10.1371/journal.pone.0016630] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
321 Zacche M, Giarenis I, Thiagamoorthy G, Robinson D, Cardozo L. Is there an association between aspects of the metabolic syndrome and overactive bladder? A prospective cohort study in women with lower urinary tract symptoms. European Journal of Obstetrics & Gynecology and Reproductive Biology 2017;217:1-5. [DOI: 10.1016/j.ejogrb.2017.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
322 Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, Guize L, Zureik M. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009;179:509-16. [PMID: 19136371 DOI: 10.1164/rccm.200807-1195OC] [Cited by in Crossref: 280] [Cited by in F6Publishing: 133] [Article Influence: 23.3] [Reference Citation Analysis]
323 Karnchanasorn R, Ou HY, Chuang LM, Chiu KC. Insulin resistance is not necessarily an essential element of metabolic syndrome. Endocrine 2013;43:92-9. [PMID: 22644836 DOI: 10.1007/s12020-012-9702-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
324 Chuengsamarn S, Rattanamongkolgul S, Sittithumcharee G, Jirawatnotai S. Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes. Diabetes Metab Syndr 2017;11:103-8. [PMID: 27697536 DOI: 10.1016/j.dsx.2016.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
325 Kim JY, Mun HS, Lee BK, Yoon SB, Choi EY, Min PK, Yoon YW, Hong BK, Rim SJ, Kwon HM. Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease. Yonsei Med J 2010;51:676-82. [PMID: 20635441 DOI: 10.3349/ymj.2010.51.5.676] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
326 Matfin G. Challenges in developing drugs for the metabolic syndrome. Curr Diab Rep 2008;8:31-6. [DOI: 10.1007/s11892-008-0007-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
327 Alexandru N, Procopciuc A, Vîlcu A, Comariţa IK, Bӑdilӑ E, Georgescu A. Extracellular vesicles-incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications. Rev Endocr Metab Disord 2021. [PMID: 34143360 DOI: 10.1007/s11154-021-09664-y] [Reference Citation Analysis]
328 Sachdev A, Marmura MJ. Metabolic syndrome and migraine. Front Neurol 2012;3:161. [PMID: 23181051 DOI: 10.3389/fneur.2012.00161] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
329 Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 2006;17:412-7. [PMID: 16832165 DOI: 10.1097/01.mol.0000236367.42755.c1] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 5.2] [Reference Citation Analysis]
330 Simonson GD, Kendall DM. Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus: . Coronary Artery Disease 2005;16:465-72. [DOI: 10.1097/00019501-200512000-00002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
331 Trajkovski M, Mziaut H, Schwarz PE, Solimena M. Genes of Type 2 Diabetes in β Cells. Endocrinology and Metabolism Clinics of North America 2006;35:357-69. [DOI: 10.1016/j.ecl.2006.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
332 Fillo J, Levcikova M, Ondrusova M, Breza J, Labas P. Importance of Different Grades of Abdominal Obesity on Testosterone Level, Erectile Dysfunction, and Clinical Coincidence. Am J Mens Health 2017;11:240-5. [PMID: 27184064 DOI: 10.1177/1557988316642213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
333 Saavedra LE. Endocannabinoid System and Cardiometabolic Risk. Clin Pharmacol Ther 2007;82:591-4. [DOI: 10.1038/sj.clpt.6100373] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
334 Novak M, Björck L, Welin L, Welin C, Manhem K, Rosengren A. Gender differences in the prevalence of metabolic syndrome in 50-year-old Swedish men and women with hypertension born in 1953. J Hum Hypertens 2013;27:56-61. [PMID: 22129609 DOI: 10.1038/jhh.2011.106] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
335 Kathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schaefer EJ, Wilson PW, D’Agostino RB, Vasan RS, Robins SJ. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation. 2006;113:20-29. [PMID: 16380547 DOI: 10.1161/circulationaha.105.567107] [Cited by in Crossref: 203] [Cited by in F6Publishing: 74] [Article Influence: 12.7] [Reference Citation Analysis]
336 Bays H, Dujovne CA. Adiposopathy is a more rational treatment target for metabolic disease than obesity alone. Curr Atheroscler Rep 2006;8:144-56. [PMID: 16510049 DOI: 10.1007/s11883-006-0052-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
337 Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Després JP. Visceral obesity and the heart. Int J Biochem Cell Biol 2008;40:821-36. [PMID: 18201922 DOI: 10.1016/j.biocel.2007.12.001] [Cited by in Crossref: 105] [Cited by in F6Publishing: 87] [Article Influence: 7.5] [Reference Citation Analysis]
338 González-muniesa P, Mártinez-gonzález M, Hu FB, Després J, Matsuzawa Y, Loos RJF, Moreno LA, Bray GA, Martinez JA. Obesity. Nat Rev Dis Primers 2017;3. [DOI: 10.1038/nrdp.2017.34] [Cited by in Crossref: 373] [Cited by in F6Publishing: 263] [Article Influence: 93.3] [Reference Citation Analysis]
339 Minhas R. Eminence-based guidelines: a quality assessment of the second Joint British Societies’ guidelines on the prevention of cardiovascular disease: JBS-2: Quality Assessment. International Journal of Clinical Practice 2007;61:1137-44. [DOI: 10.1111/j.1742-1241.2007.01310.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
340 Tørris C, Bjørnnes AK. Duration of Lactation and Maternal Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Nutrients 2020;12:E2718. [PMID: 32899507 DOI: 10.3390/nu12092718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
341 Federspil G, Nisoli E, Vettor R. A critical reflection on the definition of metabolic syndrome. Pharmacol Res. 2006;53:449-456. [PMID: 16632375 DOI: 10.1016/j.phrs.2006.03.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
342 Johnson LW, Weinstock RS. The Metabolic Syndrome: Concepts and Controversy. Mayo Clinic Proceedings 2006;81:1615-20. [DOI: 10.4065/81.12.1615] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
343 Dean E. Physical therapy in the 21st century (Part I): toward practice informed by epidemiology and the crisis of lifestyle conditions. Physiother Theory Pract 2009;25:330-53. [PMID: 19842862 DOI: 10.1080/09593980802668027] [Cited by in Crossref: 107] [Cited by in F6Publishing: 62] [Article Influence: 9.7] [Reference Citation Analysis]
344 Kawamoto R, Ninomiya D, Kasai Y, Senzaki K, Kusunoki T, Ohtsuka N, Kumagi T. Baseline and changes in serum uric acid independently predict 11-year incidence of metabolic syndrome among community-dwelling women. J Endocrinol Invest 2018;41:959-68. [DOI: 10.1007/s40618-017-0822-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
345 Bays H, Ballantyne C. Adiposopathy: why do adiposity and obesity cause metabolic disease? Future Lipidology 2006;1:389-420. [DOI: 10.2217/17460875.1.4.389] [Cited by in Crossref: 50] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
346 Ort T, Gerwien R, Lindborg KA, Diehl CJ, Lemieux AM, Eisen A, Henriksen EJ. Alterations in soleus muscle gene expression associated with a metabolic endpoint following exercise training by lean and obese Zucker rats. Physiological Genomics 2007;29:302-11. [DOI: 10.1152/physiolgenomics.00257.2006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
347 Whyte K, Kelly H, O'Dwyer V, Gibbs M, O'Higgins A, Turner MJ. Offspring birth weight and maternal fasting lipids in women screened for gestational diabetes mellitus (GDM). Eur J Obstet Gynecol Reprod Biol 2013;170:67-70. [PMID: 23809999 DOI: 10.1016/j.ejogrb.2013.04.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
348 Subramanian S, DeRosa MA, Bernal-Mizrachi C, Laffely N, Cade WT, Yarasheski KE, Cryer PE, Semenkovich CF. PPARalpha activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans. Am J Physiol Endocrinol Metab 2006;291:E1365-71. [PMID: 16868225 DOI: 10.1152/ajpendo.00230.2006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
349 Bjorge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A. Metabolic Syndrome and Endometrial Carcinoma. American Journal of Epidemiology 2010;171:892-902. [DOI: 10.1093/aje/kwq006] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
350 Pajunen P, Rissanen H, Härkänen T, Jula A, Reunanen A, Salomaa V. The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study. Diabetes Metab 2010;36:395-401. [PMID: 20673644 DOI: 10.1016/j.diabet.2010.04.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
351 Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007;115:2316-22. [PMID: 17420347 DOI: 10.1161/CIRCULATIONAHA.106.669994] [Cited by in Crossref: 157] [Cited by in F6Publishing: 56] [Article Influence: 11.2] [Reference Citation Analysis]
352 Yaturu S, Jain S. Obesity and Type 2 Diabetes. In: Preuss H, Bagchi D, editors. Obesity. CRC Press; 2007. pp. 139-54. [DOI: 10.1201/9781420005479.ch12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
353 Carlsson AC, Wändell PE, Halldin M, de Faire U, Hellénius M. Is a Unified Definition of Metabolic Syndrome Needed? Comparison of Three Definitions of Metabolic Syndrome in 60-Year-Old Men and Women. Metabolic Syndrome and Related Disorders 2009;7:231-42. [DOI: 10.1089/met.2008.0078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
354 Giacosa A, Rondanelli M. The Right Fiber for the Right Disease: An Update on the Psyllium Seed Husk and the Metabolic Syndrome. Journal of Clinical Gastroenterology 2010;44:S58-60. [DOI: 10.1097/mcg.0b013e3181e123e7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
355 Giunti S, Cooper M. Does the metabolic syndrome make blood pressure control more difficult in diabetes? Journal of Hypertension 2005;23:2155-6. [DOI: 10.1097/01.hjh.0000188730.67969.db] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
356 Rosolova H, Nussbaumerova B. Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases. EPMA J 2011;2:15-26. [PMID: 23199124 DOI: 10.1007/s13167-011-0066-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
357 Jones KL. The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? Pediatr Diabetes 2006;7:311-21. [PMID: 17212598 DOI: 10.1111/j.1399-5448.2006.00212.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
358 de Sousa G, Schlüter B, Menke T, Trowitzsch E, Andler W, Reinehr T. A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome with and without the metabolic syndrome. Metab Syndr Relat Disord 2011;9:191-6. [PMID: 21352077 DOI: 10.1089/met.2010.0081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
359 Tuomilehto J, Lindström J, Hellmich M, Lehmacher W, Westermeier T, Evers T, Brückner A, Peltonen M, Qiao Q, Chiasson JL. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score. Diabetes Res Clin Pract 2010;87:267-74. [PMID: 20022651 DOI: 10.1016/j.diabres.2009.11.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
360 Levine JH. Managing Multiple Cardiovascular Risk Factors: State of the Science. The Journal of Clinical Hypertension 2007;8:12-24. [DOI: 10.1111/j.1524-6175.2006.05924.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
361 DePaula AL, Macedo AL, Rassi N, Vencio S, Machado CA, Mota BR, Silva LQ, Halpern A, Schraibman V. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc 2008;22:2670-8. [PMID: 18347866 DOI: 10.1007/s00464-008-9808-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
362 Lee W, Chien C, Yu H, Lee S. Bladder Dysfunction in Rats With Metabolic Syndrome Induced by Long-Term Fructose Feeding. Journal of Urology 2008;179:2470-6. [DOI: 10.1016/j.juro.2008.01.086] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
363 Gluckman PD. Evolving a definition of disease. Arch Dis Child 2007;92:1053-4. [PMID: 18032637 DOI: 10.1136/adc.2007.126318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
364 Zimmet P, Alberti KGM, Serrano Ríos M. Una nueva definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: fundamento y resultados. Revista Española de Cardiología 2005;58:1371-6. [DOI: 10.1016/s0300-8932(05)74065-3] [Cited by in Crossref: 115] [Article Influence: 7.2] [Reference Citation Analysis]
365 Rachas A, Raffaitin C, Barberger-Gateau P, Helmer C, Ritchie K, Tzourio C, Amouyel P, Ducimetière P, Empana JP. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study. Heart 2012;98:650-5. [PMID: 22505463 DOI: 10.1136/heartjnl-2011-301185] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
366 Brietzke SA. Controversy in diagnosis and management of the metabolic syndrome. Med Clin North Am 2007;91:1041-61, vii-viii. [PMID: 17964908 DOI: 10.1016/j.mcna.2007.06.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
367 Laclaustra M, Corella D, Ordovas JM. Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr Metab Cardiovasc Dis 2007;17:125-39. [PMID: 17270403 DOI: 10.1016/j.numecd.2006.10.005] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 7.8] [Reference Citation Analysis]
368 Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens. 2010;23:1170-1178. [PMID: 20706196 DOI: 10.1038/ajh.2010.172] [Cited by in Crossref: 188] [Cited by in F6Publishing: 146] [Article Influence: 17.1] [Reference Citation Analysis]
369 Findeisen HM, Weckbach S, Stark RG, Reiser MF, Schoenberg SO, Parhofer KG. Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus. Cardiovasc Diabetol 2010;9:44. [PMID: 20804545 DOI: 10.1186/1475-2840-9-44] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
370 Janczura M, Bochenek G, Nowobilski R, Dropinski J, Kotula-Horowitz K, Laskowicz B, Stanisz A, Lelakowski J, Domagala T. The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function--An Occupational Cohort-Based Study. PLoS One 2015;10:e0133750. [PMID: 26274823 DOI: 10.1371/journal.pone.0133750] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
371 Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med 2010;40:397-415. [PMID: 20433212 DOI: 10.2165/11531380-000000000-00000] [Cited by in Crossref: 145] [Cited by in F6Publishing: 105] [Article Influence: 13.2] [Reference Citation Analysis]
372 Cheung BM. The metabolic syndrome in China. Br J Clin Pharmacol 2006;62:260-3. [PMID: 16934040 DOI: 10.1111/j.1365-2125.2006.02663.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
373 Singleton JR, Smith AG. Therapy insight: neurological complications of prediabetes. Nat Clin Pract Neurol 2006;2:276-82. [PMID: 16932564 DOI: 10.1038/ncpneuro0172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
374 Chew GT, Gan SK, Watts GF. Revisiting the metabolic syndrome. Medical Journal of Australia 2006;185:445-9. [DOI: 10.5694/j.1326-5377.2006.tb00644.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
375 van Vliet M, von Rosenstiel IA, Schindhelm RK, Brandjes DP, Beijnen JH, Diamant M. Ethnic differences in cardiometabolic risk profile in an overweight/obese paediatric cohort in the Netherlands: a cross-sectional study. Cardiovasc Diabetol 2009;8:2. [PMID: 19152682 DOI: 10.1186/1475-2840-8-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
376 Huh JH, Ahn SG, Kim YI, Go T, Sung KC, Choi JH, Koh KK, Kim JY. Impact of Longitudinal Changes in Metabolic Syndrome Status over 2 Years on 10-Year Incident Diabetes Mellitus. Diabetes Metab J 2019;43:530-8. [PMID: 30877706 DOI: 10.4093/dmj.2018.0111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
377 Gilstrap LG, Malhotra R, Peltier-Saxe D, Slicas D, Pineda E, Culhane-Hermann C, Cook N, Fernandez-Golarz C, Wood M. Community-based primary prevention programs decrease the rate of metabolic syndrome among socioeconomically disadvantaged women. J Womens Health (Larchmt) 2013;22:322-9. [PMID: 23540328 DOI: 10.1089/jwh.2012.3854] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
378 Parikh RM, Mohan V. Changing definitions of metabolic syndrome. Indian J Endocrinol Metab 2012;16:7-12. [PMID: 22276247 DOI: 10.4103/2230-8210.91175] [Cited by in Crossref: 66] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
379 Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am 2014;43:1-23. [PMID: 24582089 DOI: 10.1016/j.ecl.2013.09.009] [Cited by in Crossref: 276] [Cited by in F6Publishing: 190] [Article Influence: 46.0] [Reference Citation Analysis]
380 Mulè G, Cusimano P, Nardi E, Cottone S, Geraci C, Palermo A, Costanzo M, Foraci AC, Cerasola G. Relationships between metabolic syndrome and left ventricular mass in hypertensive patients: does sex matter? J Hum Hypertens. 2008;22:788-795. [PMID: 18596721 DOI: 10.1038/jhh.2008.69] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
381 Gurka MJ, Golden SH, Musani SK, Sims M, Vishnu A, Guo Y, Cardel M, Pearson TA, DeBoer MD. Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study. Diabetologia. 2017;60:1261-1270. [PMID: 28378033 DOI: 10.1007/s00125-017-4267-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
382 Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL. Lipoprotein Management in Patients With Cardiometabolic Risk. Journal of the American College of Cardiology 2008;51:1512-24. [DOI: 10.1016/j.jacc.2008.02.034] [Cited by in Crossref: 350] [Cited by in F6Publishing: 262] [Article Influence: 26.9] [Reference Citation Analysis]
383 Öhrvik J, Hedberg P, Jonason T, Lönnberg I, Nilsson G. Factor Analysis of the Individual Components of the Metabolic Syndrome Among Elderly Identifies Two Factors With Different Survival Patterns—A Population-Based Study. Metabolic Syndrome and Related Disorders 2009;7:171-8. [DOI: 10.1089/met.2008.0028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
384 Ahmadi A, Leipsic J, Feuchtner G, Gransar H, Kalra D, Heo R, Achenbach S, Andreini D, Al-Mallah M, Berman DS, Budoff M, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow B, Cury RC, Delago A, Gomez MJ, Hadamitzky M, Hausleiter J, Hindoyan N, Kaufmann PA, Kim YJ, Lin F, Maffei E, Pontone G, Raff GL, Shaw LJ, Villines TC, Dunning A, Min JK. Is metabolic syndrome predictive of prevalence, extent, and risk of coronary artery disease beyond its components? Results from the multinational coronary CT angiography evaluation for clinical outcome: an international multicenter registry (CONFIRM). PLoS One 2015;10:e0118998. [PMID: 25734639 DOI: 10.1371/journal.pone.0118998] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
385 Monami M, Marchionni N, Masotti G, Mannucci E. Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: what makes the difference? J Endocrinol Invest 2007;30:626-30. [PMID: 17923792 DOI: 10.1007/BF03347441] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
386 Gerber TC, Taylor AJ. Carotid intima-media thickness: can it close the "detection gap" for cardiovascular risk? Mayo Clin Proc 2009;84:218-20. [PMID: 19252107 DOI: 10.1016/S0025-6196(11)61137-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
387 Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome. Nutr Metab Cardiovasc Dis 2008;18:31-8. [PMID: 17420118 DOI: 10.1016/j.numecd.2006.07.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
388 Oda E, Kawai R. A cross-sectional relationship between vital capacity and diabetes in Japanese men. Diabetes Research and Clinical Practice 2009;85:111-6. [DOI: 10.1016/j.diabres.2009.04.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
389 Nilsson PM. Cardiovascular risk in the metabolic syndrome: fact or fiction? Curr Cardiol Rep 2007;9:479-85. [PMID: 17999873 DOI: 10.1007/BF02938392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
390 Ning B, Wang X, Yu Y, Waqar AB, Yu Q, Koike T, Shiomi M, Liu E, Wang Y, Fan J. High-fructose and high-fat diet-induced insulin resistance enhances atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Nutr Metab (Lond) 2015;12:30. [PMID: 26265929 DOI: 10.1186/s12986-015-0024-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
391 Ford ES, Li C. Physical activity or fitness and the metabolic syndrome. Expert Rev Cardiovasc Ther 2006;4:897-915. [PMID: 17173504 DOI: 10.1586/14779072.4.6.897] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
392 Brown TT, Cofrancesco J. Metabolic abnormalities in HIV-infected patients: An update. Curr Infect Dis Rep 2006;8. [DOI: 10.1007/s11908-006-0025-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
393 Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, Benzi L, Miccoli R, Del Prato S. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007;23:135-40. [DOI: 10.1002/dmrr.661] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
394 Zoccali C, Puntorieri E. Type-2 diabetes and endothelial dysfunction: exploring the road to disease in the reverse direction. Journal of Hypertension 2008;26:2096-100. [DOI: 10.1097/hjh.0b013e328315754e] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
395 Alessi M, Juhan-vague I. PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences. ATVB 2006;26:2200-7. [DOI: 10.1161/01.atv.0000242905.41404.68] [Cited by in Crossref: 229] [Cited by in F6Publishing: 86] [Article Influence: 15.3] [Reference Citation Analysis]
396 Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 2007;32:76-88. [PMID: 17332786 DOI: 10.1139/h06-113] [Cited by in Crossref: 254] [Cited by in F6Publishing: 181] [Article Influence: 18.1] [Reference Citation Analysis]
397 Giampaoli S, Stamler J, Donfrancesco C, Panico S, Vanuzzo D, Cesana G, Mancia G, Pilotto L, Mattiello A, Chiodini P, Palmieri L; Progetto CUORE Research Group. The metabolic syndrome: a critical appraisal based on the CUORE epidemiologic study. Prev Med 2009;48:525-31. [PMID: 19344739 DOI: 10.1016/j.ypmed.2009.03.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
398 Isbarn H, Boccon-Gibod L, Carroll PR, Montorsi F, Schulman C, Smith MR, Sternberg CN, Studer UE. Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol. 2009;55:62-75. [PMID: 18945543 DOI: 10.1016/j.eururo.2008.10.008] [Cited by in Crossref: 114] [Cited by in F6Publishing: 78] [Article Influence: 8.8] [Reference Citation Analysis]
399 Howard WJ. The metabolic syndrome: Is a critical appraisal really necessary? The point of view of a practicing physician. Nutrition, Metabolism and Cardiovascular Diseases 2006;16:85-7. [DOI: 10.1016/j.numecd.2006.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
400 Sénéchal M, Bouchard DR, Dionne IJ, Brochu M. Lifestyle habits and physical capacity in patients with moderate or severe metabolic syndrome. Metab Syndr Relat Disord 2012;10:232-40. [PMID: 22352681 DOI: 10.1089/met.2011.0136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
401 Soto González A, Bellido Guerrero D, Buño Soto M, Pértega Díaz S, De Luis D, Lopez de la Torre M, Martínez Olmos M. Does the prevalence of the metabolic syndrome improve by applying the International Diabetes Federation criteria? Public Health Nutr 2007;10:1173-80. [DOI: 10.1017/s1368980007000675] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
402 Blackett PR, Sanghera DK. Genetic determinants of cardiometabolic risk: A proposed model for phenotype association and interaction. J Clin Lipidol. 2013;7:65-81. [PMID: 23351585 DOI: 10.1016/j.jacl.2012.04.079] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
403 van Vliet M, Van der Heyden JC, Diamant M, Von Rosenstiel IA, Schindhelm RK, Aanstoot HJ, Veeze HJ. Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr 2010;156:923-9. [PMID: 20223481 DOI: 10.1016/j.jpeds.2009.12.017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
404 Kelishadi R, Salek S, Salek M, Hashemipour M, Movahedian M. Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. Jornal de Pediatria (Versão em Português) 2014;90:28-34. [DOI: 10.1016/j.jpedp.2013.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
405 Fallo F, Federspil G, Veglio F, Mulatero P. The metabolic syndrome in primary aldosteronism. Curr Diab Rep 2008;8:42-7. [DOI: 10.1007/s11892-008-0009-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
406 Khoshdel AR, Carney SL, Gillies A. Circulatory syndrome: an evolution of the metabolic syndrome concept! Curr Cardiol Rev 2012;8:68-76. [PMID: 22845817 DOI: 10.2174/157340312801215773] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
407 López-suárez A, Beltrán-robles M, Elvira-gonzález J, Alwakil M, Bascuñana-quirell A, Rosal-obrador J, Badani-gutiérrez H, Oliver-pece M, Pons-raga A, Ruiz-decastroviejo J, Cañas-hormigo F, Benítez-rodríguez E. Does diagnosis of metabolic syndrome predict the likelihood of peripheral arterial disease as defined by a low ankle-brachial index? European Journal of Cardiovascular Prevention & Rehabilitation 2008;15:693-7. [DOI: 10.1097/hjr.0b013e32830c1cc5] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
408 Schindler C. Review: The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? Therapeutic Advances in Cardiovascular Disease 2007;1:7-26. [DOI: 10.1177/1753944707082662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
409 Maron DJ, Boden WE, Spertus JA, Hartigan PM, Mancini GJ, Sedlis SP, Kostuk WJ, Chaitman BR, Shaw LJ, Berman DS, Dada M, Teo KK, Weintraub WS, O'rourke RA. Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial. Journal of the American College of Cardiology 2011;58:131-7. [DOI: 10.1016/j.jacc.2011.02.046] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
410 Gurka MJ, Ice CL, Sun SS, Deboer MD. A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc Diabetol. 2012;11:128. [PMID: 23062212 DOI: 10.1186/1475-2840-11-128] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 9.0] [Reference Citation Analysis]
411 Lee S, Bacha F, Gungor N, Arslanian S. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr. 2008;152:177-184. [PMID: 18206686 DOI: 10.1016/j.jpeds.2007.07.053] [Cited by in Crossref: 99] [Cited by in F6Publishing: 85] [Article Influence: 7.1] [Reference Citation Analysis]
412 Malayala SV, Raza A. Health behavior and perceptions among African American women with metabolic syndrome. J Community Hosp Intern Med Perspect 2016;6:30559. [PMID: 26908390 DOI: 10.3402/jchimp.v6.30559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
413 Jackson KG, Walden CM, Murray P, Smith AM, Lovegrove JA, Minihane AM, Williams CM. A sequential two meal challenge reveals abnormalities in postprandial TAG but not glucose in men with increasing numbers of metabolic syndrome components. Atherosclerosis 2012;220:237-43. [DOI: 10.1016/j.atherosclerosis.2011.09.047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
414 Beckie TM, Beckstead JW, Groer MW. The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. J Cardiovasc Nurs 2010;25:52-60. [PMID: 19935427 DOI: 10.1097/JCN.0b013e3181b7e500] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
415 Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol 2007;27:44-54. [PMID: 17245074 DOI: 10.1159/000098955] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
416 Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 2011;8:272-83. [PMID: 20807333 DOI: 10.1111/j.1743-6109.2010.01991.x] [Cited by in Crossref: 223] [Cited by in F6Publishing: 167] [Article Influence: 20.3] [Reference Citation Analysis]
417 Frisman GH, Kristenson M. Psychosocial Status and Health Related Quality of Life in Relation to the Metabolic Syndrome in a Swedish Middle-Aged Population. European Journal of Cardiovascular Nursing 2009;8:207-15. [DOI: 10.1016/j.ejcnurse.2009.01.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
418 Sadikot S, Misra A. The metabolic syndrome: An exercise in utility or futility? Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2007;1:3-21. [DOI: 10.1016/j.dsx.2006.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
419 Bo S, Rosato R, Ciccone G, Gambino R, Durazzo M, Gentile L, Cassader M, Cavallo-Perin P, Pagano G. What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects? Diabetes Metab Res Rev 2009;25:76-82. [PMID: 19145586 DOI: 10.1002/dmrr.910] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
420 Barbui C, Percudani M. Epidemiological impact of antidepressant and antipsychotic drugs on the general population. Current Opinion in Psychiatry 2006;19:405-10. [DOI: 10.1097/01.yco.0000228762.40979.8f] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
421 Grunfeld C, Rimland D, Gibert CL, Powderly WG, Sidney S, Shlipak MG, Bacchetti P, Scherzer R, Haffner SM, Heymsfield SB. Association of Upper Trunk and Visceral Adipose Tissue Volume With Insulin Resistance in Control and HIV-Infected Subjects in the FRAM Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 2007;46:283-90. [DOI: 10.1097/qai.0b013e31814b94e2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
422 Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366:1059-1062. [PMID: 16182882 DOI: 10.1016/s0140-6736(05)67402-8] [Cited by in Crossref: 4561] [Cited by in F6Publishing: 1478] [Article Influence: 285.1] [Reference Citation Analysis]
423 Grundy SM. A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor. European Heart Journal Supplements 2008;10:B16-23. [DOI: 10.1093/eurheartj/sum044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
424 Cardellini M, Marini MA, Frontoni S, Hribal ML, Andreozzi F, Perticone F, Federici M, Lauro D, Sesti G. Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2007;292:E347-52. [PMID: 16968812 DOI: 10.1152/ajpendo.00291.2006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
425 Stevenson JE, Wright BR, Boydstun AS. The metabolic syndrome and coronary artery disease: a structural equation modeling approach suggestive of a common underlying pathophysiology. Metabolism 2012;61:1582-8. [PMID: 22626764 DOI: 10.1016/j.metabol.2012.04.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
426 Fadini GP, Coracina A, Inchiostro S, Tiengo A, Avogaro A, de Kreutzenberg SV. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. European Journal of Cardiovascular Prevention & Rehabilitation 2008;15:190-6. [DOI: 10.1097/hjr.0b013e3282f17bc3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
427 Clearfield M, Pearce M, Nibbe Y, Crotty D, Wagner A. The "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation? Curr Atheroscler Rep 2014;16:380. [PMID: 24338517 DOI: 10.1007/s11883-013-0380-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
428 Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res 2008;17:1063-71. [PMID: 18777200 DOI: 10.1007/s11136-008-9385-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
429 Wiria AE, Hamid F, Wammes LJ, Prasetyani MA, Dekkers OM, May L, Kaisar MM, Verweij JJ, Guigas B, Partono F, Sartono E, Supali T, Yazdanbakhsh M, Smit JW. Infection with Soil-Transmitted Helminths Is Associated with Increased Insulin Sensitivity. PLoS One 2015;10:e0127746. [PMID: 26061042 DOI: 10.1371/journal.pone.0127746] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
430 Calleja AI, García-Bermejo P, Cortijo E, Bustamante R, Rojo Martínez E, González Sarmiento E, Fernández-Herranz R, Arenillas JF. Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke. Diabetes Care 2011;34:2413-7. [PMID: 21911778 DOI: 10.2337/dc11-1242] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
431 Lundgren JD, Malcolm R, Binks M, O'Neil PM. Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. Int J Obes (Lond) 2009;33:144-50. [PMID: 19015662 DOI: 10.1038/ijo.2008.225] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
432 Gupta RK, Gupta R, Makar N, Chaudhary S, Bhatheja H, Pathak P. The Association of Left Ventricular Mass Index with Metabolic Syndrome in Comparison to Hypertensive Patients. J Cardiovasc Echogr 2016;26:42-7. [PMID: 28465959 DOI: 10.4103/2211-4122.183748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
433 Kawamoto R, Akase T, Ninomiya D, Kumagi T, Kikuchi A. Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly Japanese. Int Urol Nephrol 2019;51:2285-94. [PMID: 31642000 DOI: 10.1007/s11255-019-02320-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
434 Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Nishio Y, Maegawa H, Koya D. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006;24:1627-1632. [PMID: 16877966 DOI: 10.1097/01.hjh.0000239299.71001.77] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 6.6] [Reference Citation Analysis]
435 Thorpe KE. Factors accounting for the rise in health-care spending in the United States: the role of rising disease prevalence and treatment intensity. Public Health 2006;120:1002-7. [PMID: 17030050 DOI: 10.1016/j.puhe.2006.09.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
436 Ng VW, Kong AP, Choi KC, Ozaki R, Wong GW, So WY, Tong PC, Sung RY, Xu LY, Chan MH, Ho CS, Lam CW, Chan JC. BMI and waist circumference in predicting cardiovascular risk factor clustering in Chinese adolescents. Obesity (Silver Spring) 2007;15:494-503. [PMID: 17299123 DOI: 10.1038/oby.2007.588] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
437 Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007;115:1806-10; discussion 1811. [PMID: 17404171 DOI: 10.1161/CIRCULATIONAHA.106.658336] [Cited by in Crossref: 106] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
438 Smith MR, O'Malley AJ, Keating NL. Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome? BJU Int 2008;101:1335-6. [PMID: 18454791 DOI: 10.1111/j.1464-410X.2008.07707.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
439 Governa P, Baini G, Borgonetti V, Cettolin G, Giachetti D, Magnano AR, Miraldi E, Biagi M. Phytotherapy in the Management of Diabetes: A Review. Molecules 2018;23:E105. [PMID: 29300317 DOI: 10.3390/molecules23010105] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
440 Singh V, Deedwania P. Reducing morbidity and mortality in high risk patients with statins. Vasc Health Risk Manag 2009;5:495-507. [PMID: 19554090 DOI: 10.2147/vhrm.s3389] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
441 Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M. Metabolic syndrome and periodontitis: is oxidative stress a common link? J Dent Res 2009;88:503-18. [PMID: 19587154 DOI: 10.1177/0022034509337479] [Cited by in Crossref: 143] [Cited by in F6Publishing: 105] [Article Influence: 11.9] [Reference Citation Analysis]
442 Cena H, Fonte ML, Turconi G. Relationship between smoking and metabolic syndrome. Nutrition Reviews 2011;69:745-53. [DOI: 10.1111/j.1753-4887.2011.00446.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
443 Saha S, Carlsson KS, Gerdtham UG, Eriksson MK, Hagberg L, Eliasson M, Johansson P. Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs study. PLoS One 2013;8:e80672. [PMID: 24244703 DOI: 10.1371/journal.pone.0080672] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
444 Sanal MG. The blind men 'see' the elephant-the many faces of fatty liver disease. World J Gastroenterol 2008;14:831-44. [PMID: 18240340 DOI: 10.3748/wjg.14.831] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
445 Yoon HJ, Ahn Y, Kim KH, Park JC, Choi DJ, Han S, Jeon ES, Cho MC, Kim JJ, Yoo BS, Shin MS, Seong IW, Kang SM, Kim YJ, Kim HS, Chae SC, Oh BH, Lee MM, Ryu KH; Korea HF Registry. The prognostic implication of metabolic syndrome in patients with heart failure. Korean Circ J 2013;43:87-92. [PMID: 23508725 DOI: 10.4070/kcj.2013.43.2.87] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
446 Qian S, Zhang M, He Y, Wang W, Liu S. Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes. Future Med Chem. 2016;8:1239-1258. [PMID: 27357615 DOI: 10.4155/fmc-2016-0064] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
447 Lastra G, Manrique C, Mcfarlane SI, Sowers JR. Cardiometabolic syndrome and chronic kidney disease. Curr Diab Rep 2006;6:207-12. [DOI: 10.1007/s11892-006-0036-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
448 Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GJ, Mcfarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow C, Cox JL, Després J, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, Mcpherson R, Poirier P, Qaadri S, Rabasa-lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif J, Tobe S, Ur E. Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group. Canadian Journal of Cardiology 2011;27:e1-e33. [DOI: 10.1016/j.cjca.2010.12.054] [Cited by in Crossref: 97] [Cited by in F6Publishing: 73] [Article Influence: 9.7] [Reference Citation Analysis]
449 Knuiman MW, Hung J, Divitini ML, Davis TM, Beilby JP. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. European Journal of Cardiovascular Prevention & Rehabilitation 2009;16:235-41. [DOI: 10.1097/hjr.0b013e32832955fc] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
450 Bauman WA, Spungen AM. Coronary heart disease in individuals with spinal cord injury: assessment of risk factors. Spinal Cord 2008;46:466-76. [PMID: 18180789 DOI: 10.1038/sj.sc.3102161] [Cited by in Crossref: 176] [Cited by in F6Publishing: 143] [Article Influence: 13.5] [Reference Citation Analysis]
451 Meigs JB. Metabolic syndrome and risk for Type 2 diabetes. Expert Review of Endocrinology & Metabolism 2014;1:57-66. [DOI: 10.1586/17446651.1.1.57] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
452 Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO. Impact of Cardiometabolic Risk Factor Clusters on Health-related Quality of Life in the U.S.*. Obesity 2007;15:511-511. [DOI: 10.1038/oby.2007.580] [Cited by in F6Publishing: 51] [Reference Citation Analysis]
453 Ruíz-Fernández NA, Leal U, Espinoza M. Comparison of scores for the classification of cardiometabolic risk in adult patients enrolled in a Venezuelan program for chronic non-communicable diseases: a cross-sectional study. Sao Paulo Med J 2020;138:69-78. [PMID: 32321108 DOI: 10.1590/1516-3180.2019.0236.R1.06112019] [Reference Citation Analysis]
454 Duncan GE. Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome. Curr Diab Rep 2006;6:29-35. [DOI: 10.1007/s11892-006-0048-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
455 Heshmat R, Shafiee G, Kelishadi R, Babaki AE, Motlagh ME, Arefirad T, Ardalan G, Ataie-Jafari A, Asayesh H, Mohammadi R, Qorbani M. Is the association of continuous metabolic syndrome risk score with body mass index independent of physical activity? The CASPIAN-III study. Nutr Res Pract 2015;9:404-10. [PMID: 26244080 DOI: 10.4162/nrp.2015.9.4.404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
456 Dempsey PC, Hadgraft NT, Winkler EAH, Clark BK, Buman MP, Gardiner PA, Owen N, Lynch BM, Dunstan DW. Associations of context-specific sitting time with markers of cardiometabolic risk in Australian adults. Int J Behav Nutr Phys Act 2018;15:114. [PMID: 30458790 DOI: 10.1186/s12966-018-0748-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
457 Chiefari E, Tanyolaç S, Iiritano S, Sciacqua A, Capula C, Arcidiacono B, Nocera A, Possidente K, Baudi F, Ventura V. A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep. 2013;3:1491. [PMID: 23512162 DOI: 10.1038/srep01491] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
458 Park S, Kim JY, Lee JH, Park H. Elevated oxidized low-density lipoprotein concentrations in postmenopausal women with the metabolic syndrome. Clinica Chimica Acta 2011;412:435-40. [DOI: 10.1016/j.cca.2010.11.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
459 Aicale R, Cipollaro L, Esposito S, Maffulli N. An evidence based narrative review on treatment of diabetic foot osteomyelitis. Surgeon 2020;18:311-20. [PMID: 32081665 DOI: 10.1016/j.surge.2020.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
460 Hamburg NM, Larson MG, Vita JA, Vasan RS, Keyes MJ, Widlansky ME, Fox CS, Mitchell GF, Levy D, Meigs JB, Benjamin EJ. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 2008;101:82-8. [PMID: 18157970 DOI: 10.1016/j.amjcard.2007.07.053] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
461 O'donnell CJ, Elosua R. Cardiovascular Risk Factors. Insights From Framingham Heart Study. Revista Española de Cardiología (English Edition) 2008;61:299-310. [DOI: 10.1016/s1885-5857(08)60118-8] [Cited by in Crossref: 23] [Article Influence: 1.8] [Reference Citation Analysis]
462 Dyck PJ, Clark VM, Overland CJ, Davies JL, Pach JM, Dyck PJ, Klein CJ, Rizza RA, Melton LJ 3rd, Carter RE, Klein R, Litchy WJ. Impaired glycemia and diabetic polyneuropathy: the OC IG Survey. Diabetes Care 2012;35:584-91. [PMID: 22355020 DOI: 10.2337/dc11-1421] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
463 Oda E, Aizawa Y. Total bilirubin is inversely associated with metabolic syndrome but not a risk factor for metabolic syndrome in Japanese men and women. Acta Diabetol 2013;50:417-22. [PMID: 23224110 DOI: 10.1007/s00592-012-0447-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
464 Varga O, Harangi M, Olsson IAS, Hansen AK. Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview: Animal models and the metabolic syndrome. Obesity Reviews 2010;11:792-807. [DOI: 10.1111/j.1467-789x.2009.00667.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
465 Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, Sattar N, Zukowska-Szczechowska E, Dominiczak AF. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int. 2007;71:816-821. [PMID: 17332732 DOI: 10.1038/sj.ki.5002160] [Cited by in Crossref: 164] [Cited by in F6Publishing: 128] [Article Influence: 11.7] [Reference Citation Analysis]
466 Klaus JR, Hurwitz BE, Llabre MM, Skyler JS, Goldberg RB, Marks JB, Bilsker MS, Schneiderman N. Central Obesity and Insulin Resistance in the Cardiometabolic Syndrome: Pathways to Preclinical Cardiovascular Structure and Function. Journal of the CardioMetabolic Syndrome 2009;4:63-71. [DOI: 10.1111/j.1559-4572.2008.00038.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
467 Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039-1049. [PMID: 18356555 DOI: 10.1161/atvbaha.107.159228] [Cited by in Crossref: 869] [Cited by in F6Publishing: 320] [Article Influence: 66.8] [Reference Citation Analysis]
468 Hsu C, Liang C, Tai Y, Cheng S. Incongruent changes in heart rate variability and body weight after discontinuing aerobic exercise in patients with schizophrenia. International Journal of Psychophysiology 2016;109:132-7. [DOI: 10.1016/j.ijpsycho.2016.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
469 Henry NJ, Smith TW, Butner J, Berg CA, Sewell KK, Uchino BN. Marital quality, depressive symptoms, and the metabolic syndrome: a couples structural model. J Behav Med 2015;38:497-506. [PMID: 25677374 DOI: 10.1007/s10865-015-9619-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
470 Cheung BM, Leung Ong K, Man YB, Wong LY, Lau C, Lam KS. Prevalence of the Metabolic Syndrome in the United States National Health and Nutrition Examination Survey 1999?2002 According to Different Defining Criteria. J Clin Hypertension 2006;8:562-70. [DOI: 10.1111/j.1524-6175.2006.05414.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
471 Rył A, Rotter I, Słojewski M, Jędrzychowska A, Marcinowska Z, Grabowska M, Laszczyńska M. Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)? Int J Environ Res Public Health 2015;12:3327-42. [PMID: 25809513 DOI: 10.3390/ijerph120303327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
472 Sundström J, Risérus U, Byberg L, Zethelius B, Lithell H, Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 2006;332:878-82. [PMID: 16510492 DOI: 10.1136/bmj.38766.624097.1F] [Cited by in Crossref: 243] [Cited by in F6Publishing: 79] [Article Influence: 16.2] [Reference Citation Analysis]
473 Pimienta González R, Couto Comba P, Rodríguez Esteban M, Alemán Sánchez JJ, Hernández Afonso J, Rodríguez Pérez MD, Marcelino Rodríguez I, Brito Díaz B, Elosua R, Cabrera de León A. Incidence, Mortality and Positive Predictive Value of Type 1 Cardiorenal Syndrome in Acute Coronary Syndrome. PLoS One 2016;11:e0167166. [PMID: 27907067 DOI: 10.1371/journal.pone.0167166] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
474 Yuan G, Hegele RA. Genetic forms of the cardiometabolic syndrome: what can they tell the clinician? J Cardiometab Syndr 2007;2:45-8. [PMID: 17684446 DOI: 10.1111/j.1559-4564.2007.05905.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
475 Shah S, Novak S, Stapleton LM. Evaluation and comparison of models of metabolic syndrome using confirmatory factor analysis. Eur J Epidemiol 2006;21:343-9. [PMID: 16736276 DOI: 10.1007/s10654-006-9004-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
476 Unwin N. The metabolic syndrome. J R Soc Med 2006;99:457-62. [PMID: 16946389 DOI: 10.1258/jrsm.99.9.457] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
477 Volek JS, Feinman RD. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005;2:31. [PMID: 16288655 DOI: 10.1186/1743-7075-2-31] [Cited by in Crossref: 134] [Cited by in F6Publishing: 114] [Article Influence: 8.4] [Reference Citation Analysis]
478 Suzuki T, Homma S. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome. Med Clin North Am 2007;91:1211-23, x. [PMID: 17964917 DOI: 10.1016/j.mcna.2007.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
479 Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881-887. [PMID: 17167477 DOI: 10.1038/nature05488] [Cited by in Crossref: 2577] [Cited by in F6Publishing: 2102] [Article Influence: 184.1] [Reference Citation Analysis]
480 Kiess W, Blüher S, Kapellen T, Körner A. Metabolic Syndrome in Children and Adolescents: Prevalence, Public Health Issue, and Time for Initiative. Journal of Pediatric Gastroenterology & Nutrition 2009;49:268-71. [DOI: 10.1097/mpg.0b013e31819a4e9d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
481 Desai N, Roman A, Rochelson B, Gupta M, Xue X, Chatterjee PK, Tam Tam H, Metz CN. Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome. Am J Obstet Gynecol 2013;209:136.e1-9. [PMID: 23659985 DOI: 10.1016/j.ajog.2013.05.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
482 Zeidan M, Rayan M, Zeidan N, Falah M, Rayan A. Indexing Natural Products for Their Potential Anti-Diabetic Activity: Filtering and Mapping Discriminative Physicochemical Properties. Molecules 2017;22:E1563. [PMID: 28926980 DOI: 10.3390/molecules22091563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
483 Sharif A, Ravindran V, Dunseath G, Luzio S, Owens DR, Baboolal K. Comparison of Rival Metabolic Syndrome Classifications Against Pathophysiological Markers in Renal Transplant Recipients. Transplantation 2010;89:347-52. [DOI: 10.1097/tp.0b013e3181bd06d2] [Cited by in Crossref: 12] [Article Influence: 1.1] [Reference Citation Analysis]
484 Maruotti N, d’Onofrio F, Cantatore FP. Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy. Clin Exp Med 2015;15:433-8. [DOI: 10.1007/s10238-014-0323-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
485 Sambataro M, Perseghin G, Lattuada G, Beltramello G, Luzi L, Pacini G. Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines. Acta Diabetol 2013;50:301-7. [DOI: 10.1007/s00592-011-0366-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
486 Parker B, Bruce IN. The Metabolic Syndrome in Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 2010;36:81-97. [DOI: 10.1016/j.rdc.2009.12.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
487 Li Y, Yang X, Zhai F, Kok FJ, Zhao W, Piao J, Zhang J, Cui Z, Ma G. Prevalence of the metabolic syndrome in Chinese adolescents. Br J Nutr 2008;99:565-70. [PMID: 17662161 DOI: 10.1017/S0007114507797064] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
488 Guembe M, Toledo E, Barba J, Martínez-vila E, González-diego P, Irimia P, Díez J, Viñes J. Association between metabolic syndrome or its components and asymptomatic cardiovascular disease in the RIVANA-study. Atherosclerosis 2010;211:612-7. [DOI: 10.1016/j.atherosclerosis.2010.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
489 Li G, Xie F, Yan S, Hu X, Jin B, Wang J, Wu J, Yin D, Xie Q. Subhealth: definition, criteria for diagnosis and potential prevalence in the central region of China. BMC Public Health 2013;13:446. [PMID: 23642312 DOI: 10.1186/1471-2458-13-446] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
490 Monami M, Pala L, Bardini G, Francesconi P, Cresci B, Marchionni N, Rotella CM, Mannucci E. Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study. Acta Diabetol 2009;46:191-6. [PMID: 18989613 DOI: 10.1007/s00592-008-0074-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
491 Monami M, Balzi D, Lamanna C, Melani C, Cocca C, Lotti E, Fedeli A, Masotti G, Marchionni N, Mannucci E. Prognostic value of serum liver enzymes levels in type 2 diabetic patients. Diabetes Metab Res Rev 2007;23:625-30. [DOI: 10.1002/dmrr.744] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
492 Moreno B, Casanueva F. Identificación, diagnóstico y control del paciente con obesidad abdominal y factores de riesgo cardiovascular y metabólico. Medicina Clínica 2007;128:429-37. [DOI: 10.1157/13100347] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
493 Holvoet P. Stress in obesity and associated metabolic and cardiovascular disorders. Scientifica (Cairo) 2012;2012:205027. [PMID: 24278677 DOI: 10.6064/2012/205027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
494 Sawant SP, Amin AS. Use of Continuous Metabolic Syndrome Score in Overweight and Obese Children. Indian J Pediatr 2019;86:909-14. [PMID: 31300954 DOI: 10.1007/s12098-019-02994-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
495 Cara JF, Chaiken RL. Type 2 diabetes and the metabolic syndrome in children and adolescents. Curr Diab Rep 2006;6:241-50. [PMID: 16898579 DOI: 10.1007/s11892-006-0041-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
496 Lau DCW. Metabolic syndrome: Perception or reality? Curr Atheroscler Rep 2009;11:264-71. [DOI: 10.1007/s11883-009-0041-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
497 Michels KA, McNeel TS, Trabert B. Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data. Gynecol Oncol 2019;155:294-300. [PMID: 31495456 DOI: 10.1016/j.ygyno.2019.08.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
498 Ishizaka N, Ishizaka Y, Yamakado M, Toda E, Koike K, Nagai R. Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test. Atherosclerosis 2009;204:619-23. [PMID: 19056083 DOI: 10.1016/j.atherosclerosis.2008.10.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
499 Smith KW, Krieger N, Kosheleva A, Urato M, Waterman PD, Williams DR, Carney DR, Chen JT, Bennett GG, Freeman E. A Structural Model of Social Determinants of the Metabolic Syndrome. Ethn Dis 2020;30:331-8. [PMID: 32346279 DOI: 10.18865/ed.30.2.331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
500 Rejas J, Bobes J, Arango C, Aranda P, Carmena R, Garcia-garcia M. Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: A corollary from the CLAMORS study. Schizophrenia Research 2008;99:23-8. [DOI: 10.1016/j.schres.2007.10.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
501 Warensjo E, Nolan D, Tapsell L. Dairy food consumption and obesity-related chronic disease. Adv Food Nutr Res 2010;59:1-41. [PMID: 20610172 DOI: 10.1016/S1043-4526(10)59001-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
502 Heiss G, Snyder ML, Teng Y, Schneiderman N, Llabre MM, Cowie C, Carnethon M, Kaplan R, Giachello A, Gallo L, Loehr L, Avilés-Santa L. Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic Community Health Study/Study of Latinos. Diabetes Care 2014;37:2391-9. [PMID: 25061141 DOI: 10.2337/dc13-2505] [Cited by in Crossref: 104] [Cited by in F6Publishing: 74] [Article Influence: 17.3] [Reference Citation Analysis]
503 Zhang Y, Hong J, Gu W, Gui M, Chen Y, Zhang Y, Chi Z, Wang W, Li X, Ning G. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease. Endocr 2009;36:233-8. [DOI: 10.1007/s12020-009-9214-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
504 Robinson MD, Mishra I, Deodhar S, Patel V, Gordon KV, Vintimilla R, Brown K, Johnson L, O'Bryant S, Cistola DP. Water T2 as an early, global and practical biomarker for metabolic syndrome: an observational cross-sectional study. J Transl Med 2017;15:258. [PMID: 29258604 DOI: 10.1186/s12967-017-1359-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
505 Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO. Productivity costs associated with cardiometabolic risk factor clusters in the United States. Value Health 2007;10:443-50. [PMID: 17970926 DOI: 10.1111/j.1524-4733.2007.00199.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
506 Profit L, Chrisp P, Nadin C. Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus. Core Evid 2008;3:13-30. [PMID: 20694081 DOI: 10.3355/ce.2008.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
507 Santos A, Barros H. Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Diabetes and Vascular Disease Research 2007;4:320-7. [DOI: 10.3132/dvdr.2007.059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
508 Chen J, Townsend RR. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome. Expert Opin Pharmacother 2007;8:2001-9. [PMID: 17714054 DOI: 10.1517/14656566.8.13.2001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
509 Stuart CA, McCurry MP, Marino A, South MA, Howell ME, Layne AS, Ramsey MW, Stone MH. Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness. J Clin Endocrinol Metab 2013;98:2027-36. [PMID: 23515448 DOI: 10.1210/jc.2012-3876] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 11.5] [Reference Citation Analysis]
510 Margozzini P, Rigotti A, Ferreccio C, Quezada N, Garrido M, Valdés G. Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world. Ther Adv Cardiovasc Dis 2007;1:83-90. [PMID: 19124397 DOI: 10.1177/1753944707082716] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
511 Halcox J, Misra A. Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat? Metab Syndr Relat Disord 2015;13:1-21. [PMID: 25402738 DOI: 10.1089/met.2014.0049] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
512 Melo AS, Vieira CS, Romano LGM, Ferriani RA, Navarro PA. The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism. Reprod Sci 2011;18:1230-6. [DOI: 10.1177/1933719111414205] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
513 von Känel R, Mausbach BT, Dimsdale JE, Mills PJ, Patterson TL, Ancoli-Israel S, Ziegler MG, Roepke SK, Harmell AL, Allison M, Grant I. Regular physical activity moderates cardiometabolic risk in Alzheimer's caregivers. Med Sci Sports Exerc 2011;43:181-9. [PMID: 20473220 DOI: 10.1249/MSS.0b013e3181e6d478] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
514 Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol. Eur J Endocrinol 2008;158:53-60. [PMID: 18166817 DOI: 10.1530/EJE-07-0451] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
515 Baracco R, Mohanna S, Seclén S. A comparison of the prevalence of metabolic syndrome and its components in high and low altitude populations in peru. Metab Syndr Relat Disord 2007;5:55-62. [PMID: 18370814 DOI: 10.1089/met.2006.0019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
516 Solera-martínez M, López-martínez S, Sánchez-lópez M, Moya-martínez P, Notario-pacheco B, Arias-palencia N, Franquelo-morales P, Martínez-vizcaíno V. Validez de un modelo con un único factor en el síndrome metabólico en adultos jóvenes: análisis factorial confirmatorio. Revista Española de Cardiología 2011;64:379-84. [DOI: 10.1016/j.recesp.2010.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
517 Wilkerson GB, Bullard JT, Bartal DW. Identification of cardiometabolic risk among collegiate football players. J Athl Train 2010;45:67-74. [PMID: 20064051 DOI: 10.4085/1062-6050-45.1.67] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
518 Ness-Abramof R, Apovian CM. Waist circumference measurement in clinical practice. Nutr Clin Pract. 2008;23:397-404. [PMID: 18682591 DOI: 10.1177/0884533608321700] [Cited by in Crossref: 91] [Cited by in F6Publishing: 62] [Article Influence: 7.6] [Reference Citation Analysis]
519 Blann AD. Angiogenesis, the metabolic syndrome and heart disease: is there a connection?: Editorial: The metabolic syndrome and heart disease. Journal of Internal Medicine 2010;268:312-5. [DOI: 10.1111/j.1365-2796.2010.02271.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
520 Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther 2007;82:509-24. [PMID: 17851562 DOI: 10.1038/sj.clpt.6100355] [Cited by in Crossref: 107] [Cited by in F6Publishing: 84] [Article Influence: 7.6] [Reference Citation Analysis]
521 Kim S, Chang Y, Yun KE, Jung H, Kim I, Hyun YY, Lee K, Joo KJ, Park HJ, Shin H, Ryu S. Metabolically healthy and unhealthy obesity phenotypes and risk of renal stone: a cohort study. Int J Obes 2019;43:852-61. [DOI: 10.1038/s41366-018-0140-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
522 Kawamoto R, Kikuchi A, Akase T, Ninomiya D, Kasai Y, Ohtsuka N, Kumagi T. Total bilirubin independently predicts incident metabolic syndrome among community-dwelling women. Diabetes Metab Syndr 2019;13:1329-34. [PMID: 31336487 DOI: 10.1016/j.dsx.2019.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ. Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev 2014;23:2349-56. [PMID: 25304929 DOI: 10.1158/1055-9965.EPI-14-0458] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 8.9] [Reference Citation Analysis]
524 Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The Metabolic Syndrome and Cardiovascular Risk. Journal of the American College of Cardiology 2010;56:1113-32. [DOI: 10.1016/j.jacc.2010.05.034] [Cited by in Crossref: 1421] [Cited by in F6Publishing: 1077] [Article Influence: 129.2] [Reference Citation Analysis]
525 Guo Y, Hsu Y, Liang A, Lu W, Wu C, Lee H, Huang S. n-3 Polyunsaturated fatty acids ameliorate cognitive age-related impairments and depressive behaviour in unchallenged aged prediabetic rats. Journal of Functional Foods 2015;19:522-36. [DOI: 10.1016/j.jff.2015.09.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
526 Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007;7:220. [PMID: 17727697 DOI: 10.1186/1471-2458-7-220] [Cited by in Crossref: 197] [Cited by in F6Publishing: 145] [Article Influence: 14.1] [Reference Citation Analysis]
527 Nesbitt MJ, Reynolds MA, Shiau H, Choe K, Simonsick EM, Ferrucci L. Association of periodontitis and metabolic syndrome in the Baltimore Longitudinal Study of Aging. Aging Clin Exp Res 2010;22:238-42. [PMID: 20634647 DOI: 10.1007/BF03324802] [Cited by in Crossref: 42] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
528 Rey-lópez JP, de Rezende LF, Pastor-valero M, Tess BH. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used: Prevalence of metabolically healthy obesity. Obes Rev 2014;15:781-90. [DOI: 10.1111/obr.12198] [Cited by in Crossref: 130] [Cited by in F6Publishing: 105] [Article Influence: 18.6] [Reference Citation Analysis]
529 Oikonomou E, Mourouzis K, Fountoulakis P, Papamikroulis GA, Siasos G, Antonopoulos A, Vogiatzi G, Tsalamadris S, Vavuranakis M, Tousoulis D. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance. Heart Fail Rev 2018;23:389-408. [PMID: 29453696 DOI: 10.1007/s10741-018-9682-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
530 Alexander CM, Landsman PB, Grundy SM. Metabolic syndrome and hyperglycemia: congruence and divergence. Am J Cardiol 2006;98:982-5. [PMID: 16996888 DOI: 10.1016/j.amjcard.2006.04.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
531 Corbatón Anchuelo A, Serrano Ríos M. Criterios de clasificación y significación clínica del síndrome metabólico. Revista Clínica Española 2006;206:447-50. [DOI: 10.1157/13093472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
532 Cusimano MC, Pudwell J, Roddy M, Cho CJ, Smith GN. The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications. American Journal of Obstetrics and Gynecology 2014;210:438.e1-9. [DOI: 10.1016/j.ajog.2013.12.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 9.6] [Reference Citation Analysis]
533 Matfin G. The metabolic syndrome: what's in a name? Ther Adv Endocrinol Metab 2010;1:39-45. [PMID: 23148148 DOI: 10.1177/2042018810374290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
534 Aronne LJ. Cardiovascular Risk Reduction: Focus on Managing Cardiometabolic Risk Factors. Obesity 2006;14:119S-20S. [DOI: 10.1038/oby.2006.290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
535 de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. The Lancet Oncology 2010;11:193-203. [DOI: 10.1016/s1470-2045(09)70287-6] [Cited by in Crossref: 130] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
536 Lee H, Cheng W, Huang BET, Hsu Y, Huang S. Anti-inflammatory and hypoglycemic efficacy of Poria cocos and Dioscorea opposita in prediabetes mellitus rats. RSC Adv 2014;4:55649-57. [DOI: 10.1039/c4ra10539g] [Cited by in Crossref: 11] [Article Influence: 1.6] [Reference Citation Analysis]
537 Bédard A, Dodin S, Corneau L, Lemieux S. Impact of the Traditional Mediterranean Diet on the Framingham Risk Score and the Metabolic Syndrome According to Sex. Metabolic Syndrome and Related Disorders 2014;12:95-101. [DOI: 10.1089/met.2012.0076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
538 Akintunde AA, Ayodele OE, Akinwusi PO, Opadijo GO. Metabolic syndrome: comparison of occurrence using three definitions in hypertensive patients. Clin Med Res 2011;9:26-31. [PMID: 20682756 DOI: 10.3121/cmr.2010.902] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
539 Cavallari I, Cannon CP, Braunwald E, Goodrich EL, Im K, Lukas MA, O'Donoghue ML. Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome. Eur J Prev Cardiol 2018;25:830-8. [PMID: 29537291 DOI: 10.1177/2047487318763897] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
540 Ingelsson E, Arnlöv J, Lind L, Sundström J. Metabolic syndrome and risk for heart failure in middle-aged men. Heart. 2006;92:1409-1413. [PMID: 16717067 DOI: 10.1136/hrt.2006.089011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
541 Pandey PK, Swami A, Biswas TK, Thakuria R. Prevalence of Metabolic Syndrome in Treatment Naïve Rheumatoid Arthritis and Correlation With Disease Parameters. Arch Rheumatol 2017;32:46-52. [PMID: 30375525 DOI: 10.5606/ArchRheumatol.2017.5949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
542 Lee J, Heng D, Ma S, Chew SK, Hughes K, Tai ES. The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study. Clin Endocrinol (Oxf). 2008;69:225-230. [PMID: 18208579 DOI: 10.1111/j.1365-2265.2008.03174.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
543 Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, Feig DI, Shafiu M, Segal M, Glassock RJ, Shimada M, Roncal C, Nakagawa T. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009;30:96-116. [PMID: 19151107 DOI: 10.1210/er.2008-0033] [Cited by in Crossref: 303] [Cited by in F6Publishing: 252] [Article Influence: 25.3] [Reference Citation Analysis]
544 Guri AJ, Hontecillas R, Bassaganya-riera J. Peroxisome proliferator-activated receptors: Bridging metabolic syndrome with molecular nutrition. Clinical Nutrition 2006;25:871-85. [DOI: 10.1016/j.clnu.2006.08.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
545 Abdalla-Aslan R, Findler M, Levin L, Zini A, Shay B, Twig G, Almoznino G. Where periodontitis meets metabolic syndrome-The role of common health-related risk factors. J Oral Rehabil 2019;46:647-56. [PMID: 30958576 DOI: 10.1111/joor.12798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
546 Goodman E, Li C, Tu YK, Ford E, Sun SS, Huang TT. Stability of the factor structure of the metabolic syndrome across pubertal development: confirmatory factor analyses of three alternative models. J Pediatr 2009;155:S5.e1-8. [PMID: 19732562 DOI: 10.1016/j.jpeds.2009.04.045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
547 Wong VW, Wong GL, Tsang SW, Hui AY, Chan AW, Choi PC, Chim AM, Chu S, Chan FK, Sung JJ, Chan HL. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther 2009;29:387-96. [PMID: 19035982 DOI: 10.1111/j.1365-2036.2008.03896.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
548 Doshi KB, Kashyap SR, Brennan DM, Hoar BM, Cho L, Hoogwerf BJ. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study. Diabetes, Obesity and Metabolism 2009;11:102-8. [DOI: 10.1111/j.1463-1326.2008.00908.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
549 Berk PD. Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome. Hepatology 2008;48:1362-76. [PMID: 18972439 DOI: 10.1002/hep.22632] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
550 Huang K, Lee L, Chen C, Sung P. All-cause and Cardiovascular Disease Mortality Increased With Metabolic Syndrome in Taiwanese. Obesity 2008;16:684-9. [DOI: 10.1038/oby.2007.112] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
551 van Dongen J, Willemsen G, Chen WM, de Geus EJ, Boomsma DI. Heritability of metabolic syndrome traits in a large population-based sample. J Lipid Res 2013;54:2914-23. [PMID: 23918046 DOI: 10.1194/jlr.P041673] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 7.1] [Reference Citation Analysis]
552 Ritz E, Dikow R. Hypertension and antihypertensive treatment of diabetic nephropathy. Nat Rev Nephrol 2006;2:562-7. [DOI: 10.1038/ncpneph0298] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
553 Deka R, Durakovic Z, Niu W, Zhang G, Karns R, Smolej-Narancic N, Missoni S, Caric D, Caric T, Rudan D, Salzer B, Chakraborty R, Rudan P. Prevalence of metabolic syndrome and related metabolic traits in an island population of the Adriatic. Ann Hum Biol 2012;39:46-53. [PMID: 22149059 DOI: 10.3109/03014460.2011.637512] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
554 van Vliet M, Heymans MW, von Rosenstiel IA, Brandjes DP, Beijnen JH, Diamant M. Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol 2011;10:106. [PMID: 22114790 DOI: 10.1186/1475-2840-10-106] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
555 Torres-Rovira L, Astiz S, Caro A, Lopez-Bote C, Ovilo C, Pallares P, Perez-Solana ML, Sanchez-Sanchez R, Gonzalez-Bulnes A. Diet-induced swine model with obesity/leptin resistance for the study of metabolic syndrome and type 2 diabetes. ScientificWorldJournal 2012;2012:510149. [PMID: 22629144 DOI: 10.1100/2012/510149] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
556 Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008;10:607-16. [PMID: 18657245 DOI: 10.1111/j.1399-5618.2008.00599.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 6.1] [Reference Citation Analysis]
557 Berglund L, Lefevre M, Ginsberg HN, Kris-etherton PM, Elmer PJ, Stewart PW, Ershow A, Pearson TA, Dennis BH, Roheim PS, Ramakrishnan R, Reed R, Stewart K, Phillips KM; DELTA Investigators. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. The American Journal of Clinical Nutrition 2007;86:1611-20. [DOI: 10.1093/ajcn/86.5.1611] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
558 Ritz E. Metabolic syndrome: an emerging threat to renal function. Clin J Am Soc Nephrol. 2007;2:869-871. [PMID: 17702719 DOI: 10.2215/cjn.02350607] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
559 Lovegrove JA. CVD risk in South Asians: the importance of defining adiposity and influence of dietary polyunsaturated fat. Proc Nutr Soc 2007;66:286-98. [PMID: 17466109 DOI: 10.1017/S0029665107005514] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
560 Aronne LJ, Isoldi KK. Cannabinoid-1 Receptor Blockade in Cardiometabolic Risk Reduction: Efficacy. The American Journal of Cardiology 2007;100:S18-26. [DOI: 10.1016/j.amjcard.2007.10.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
561 Lender D, Sysko SK. The Metabolic Syndrome and Cardiometabolic Risk: Scope of the Problem and Current Standard of Care. Pharmacotherapy 2006;26:3S-12S. [DOI: 10.1592/phco.26.5part2.3s] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
562 Huh JH, Kang DR, Jang JY, Shin JH, Kim JY, Choi S, Cho EJ, Park JS, Sohn IS, Jo SH, Sung KC, Koh KK. Metabolic syndrome epidemic among Korean adults: Korean survey of Cardiometabolic Syndrome (2018). Atherosclerosis 2018;277:47-52. [PMID: 30172084 DOI: 10.1016/j.atherosclerosis.2018.08.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
563 Alefishat EA, Abu Farha RK, Al-Debei MM. Self-Reported Adherence among Individuals at High Risk of Metabolic Syndrome: Effect of Knowledge and Attitude. Med Princ Pract 2017;26:157-63. [PMID: 27816978 DOI: 10.1159/000453037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
564 Tsunoda K, Shimajiri Y, Morita S, Furuta M, Kadoya Y, Yamada S, Nanjo K, Sanke T. Chronic Kidney Disease Has a More Powerful Impact on Peripheral Arterial Disease Than Metabolic Syndrome in Japanese Type 2 Diabetic Patients. Metabolic Syndrome and Related Disorders 2009;7:323-6. [DOI: 10.1089/met.2008.0074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
565 Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gökce C, Kalkan A, Yazıcı C. Prevalence of Metabolic Syndrome in the Mediterranean Region of Turkey: Evaluation of Hypertension, Diabetes Mellitus, Obesity, and Dyslipidemia. Metabolic Syndrome and Related Disorders 2009;7:427-34. [DOI: 10.1089/met.2008.0068] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
566 Essah PA, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest 2006;29:270-80. [PMID: 16682845 DOI: 10.1007/BF03345554] [Cited by in Crossref: 77] [Cited by in F6Publishing: 24] [Article Influence: 5.1] [Reference Citation Analysis]
567 Ahanchi NS, Hadaegh F, Alipour A, Ghanbarian A, Azizi F, Khalili D. Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study. Sci Rep 2019;9:1572. [PMID: 30733469 DOI: 10.1038/s41598-018-38095-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
568 Zubair N, Kuzawa CW, Lee NR, McDade TW, Adair LS. Clustering and determinants of cardiometabolic risk factors among Filipino young adults. Asia Pac J Clin Nutr 2014;23:148-58. [PMID: 24561983 DOI: 10.6133/apjcn.2014.23.1.06] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
569 Yu J, Pudwell J, Dayan N, Smith GN. Postpartum Breastfeeding and Cardiovascular Risk Assessment in Women Following Pregnancy Complications. Journal of Women's Health 2020;29:627-35. [DOI: 10.1089/jwh.2019.7894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
570 Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care 2010;33:2457-61. [PMID: 20699434 DOI: 10.2337/dc10-0942] [Cited by in Crossref: 85] [Cited by in F6Publishing: 66] [Article Influence: 7.7] [Reference Citation Analysis]
571 Smith GN, Pudwell J, Walker M, Wen S. Risk Estimation of Metabolic Syndrome at One and Three Years After a Pregnancy Complicated by Preeclampsia. Journal of Obstetrics and Gynaecology Canada 2012;34:836-41. [DOI: 10.1016/s1701-2163(16)35382-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 4.1] [Reference Citation Analysis]
572 Park S, Lindholm B. Definition of Metabolic Syndrome in Peritoneal Dialysis. Perit Dial Int 2009;29:137-44. [DOI: 10.1177/089686080902902s27] [Cited by in Crossref: 15] [Article Influence: 1.3] [Reference Citation Analysis]
573 Leite ML, Nicolosi A, Firmo JO, Lima-Costa MF. Features of metabolic syndrome in non-diabetic Italians and Brazilians: a discriminant analysis. Int J Clin Pract 2007;61:32-8. [PMID: 17229178 DOI: 10.1111/j.1742-1241.2006.01139.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
574 de Oliveira CM, Pereira AC, de Andrade M, Soler JM, Krieger JE. Heritability of cardiovascular risk factors in a Brazilian population: Baependi Heart Study. BMC Med Genet 2008;9. [DOI: 10.1186/1471-2350-9-32] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
575 Cupul-Uicab LA, Skjaerven R, Haug K, Travlos GS, Wilson RE, Eggesbø M, Hoppin JA, Whitworth KW, Longnecker MP. Exposure to tobacco smoke in utero and subsequent plasma lipids, ApoB, and CRP among adult women in the MoBa cohort. Environ Health Perspect 2012;120:1532-7. [PMID: 22814200 DOI: 10.1289/ehp.1104563] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
576 Broekhuizen LN, Boekholdt SM, Arsenault BJ, Despres J, Stroes ES, Kastelein JJ, Khaw K, Wareham NJ. Physical activity, metabolic syndrome, and coronary risk: the EPIC–Norfolk prospective population study. European Journal of Cardiovascular Prevention & Rehabilitation 2011;18:209-17. [DOI: 10.1177/1741826710389397] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
577 Oda E. Criteria for diagnosing the metabolic syndrome. Am J Clin Nutr 2006;84:1251-2; author reply 1252. [PMID: 17093185 DOI: 10.1093/ajcn/84.5.1251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
578 Silva LRBE, Zamunér AR, Gentil P, Alves FM, Leal AGF, Soares V, Silva MS, Vieira MF, Simões K, Pedrino GR, Rebelo ACS. Cardiac Autonomic Modulation and the Kinetics of Heart Rate Responses in the On- and Off-Transient during Exercise in Women with Metabolic Syndrome. Front Physiol 2017;8:542. [PMID: 28798697 DOI: 10.3389/fphys.2017.00542] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
579 Wijndaele K, Duvigneaud N, Matton L, Duquet W, Thomis M, Beunen G, Lefevre J, Philippaerts RM. Muscular Strength, Aerobic Fitness, and Metabolic Syndrome Risk in Flemish Adults. Medicine & Science in Sports & Exercise 2007;39:233-40. [DOI: 10.1249/01.mss.0000247003.32589.a6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 6.7] [Reference Citation Analysis]
580 Parker B, Ahmad Y, Shelmerdine J, Edlin H, Yates AP, Teh LS, Bruce IN. An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus. Lupus 2011;20:1459-65. [PMID: 21893561 DOI: 10.1177/0961203311416695] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
581 Alberti KG, Zimmet PZ. Should we dump the metabolic syndrome? No. BMJ. 2008;336:641. [PMID: 18356232 DOI: 10.1136/bmj.39484.636586.94] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
582 Tsukiyama H, Nagai Y, Matsubara F, Shimizu H, Iwamoto T, Yamanouchi E, Sada Y, Kato H, Ohta A, Tanaka Y. Proposed cut-off values of the waist circumference for metabolic syndrome based on visceral fat volume in a Japanese population. J Diabetes Investig 2016;7:587-93. [PMID: 27181599 DOI: 10.1111/jdi.12454] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
583 Lin JD, Lin LP, Liou SW, Chen YC, Hsu SW, Liu CT. Gender differences in the prevalence of metabolic syndrome and its components among adults with disabilities based on a community health check up data. Res Dev Disabil 2013;34:516-20. [PMID: 23085500 DOI: 10.1016/j.ridd.2012.09.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
584 Boyer L, Richieri R, Dassa D, Boucekine M, Fernandez J, Vaillant F, Padovani R, Auquier P, Lancon C. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia. Psychiatry Res 2013;210:381-6. [PMID: 23850204 DOI: 10.1016/j.psychres.2013.06.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
585 Gans RO. The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms. Med Clin North Am 2006;90:573-91. [PMID: 16843763 DOI: 10.1016/j.mcna.2006.05.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
586 Mimoun E, Aggoun Y, Pousset M, Dubern B, Bouglé D, Girardet JP, Basdevant A, Bonnet D, Tounian P. Association of arterial stiffness and endothelial dysfunction with metabolic syndrome in obese children. J Pediatr 2008;153:65-70. [PMID: 18571538 DOI: 10.1016/j.jpeds.2007.12.048] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
587 Grover S, Nebhinani N, Chakrabarti S, Avasthi A, Kulhara P. Metabolic Syndrome in Drug-naïve Patients with Depressive Disorders. Indian J Psychol Med 2013;35:167-73. [PMID: 24049228 DOI: 10.4103/0253-7176.116247] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
588 Loucks EB, Rehkopf DH, Thurston RC, Kawachi I. Socioeconomic disparities in metabolic syndrome differ by gender: evidence from NHANES III. Ann Epidemiol 2007;17:19-26. [PMID: 17140811 DOI: 10.1016/j.annepidem.2006.07.002] [Cited by in Crossref: 147] [Cited by in F6Publishing: 118] [Article Influence: 9.8] [Reference Citation Analysis]
589 Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol. 2013;189:S34-42; discussion S43-S44. [PMID: 23234628 DOI: 10.1016/j.juro.2012.11.017] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 8.6] [Reference Citation Analysis]
590 Cameron A. The metabolic syndrome: Validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. Maturitas 2010;65:117-21. [DOI: 10.1016/j.maturitas.2009.11.026] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
591 Fall T, Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol 2014;382:740-57. [PMID: 22963884 DOI: 10.1016/j.mce.2012.08.018] [Cited by in Crossref: 180] [Cited by in F6Publishing: 136] [Article Influence: 20.0] [Reference Citation Analysis]
592 Ballantyne CM. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends? Crit Pathw Cardiol 2007;6:41-5. [PMID: 17667863 DOI: 10.1097/HPC.0b013e318053d190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
593 Ning H, Van Horn L, Shay CM, Lloyd-Jones DM. Associations of dietary fiber intake with long-term predicted cardiovascular disease risk and C-reactive protein levels (from the National Health and Nutrition Examination Survey Data [2005-2010]). Am J Cardiol 2014;113:287-91. [PMID: 24176070 DOI: 10.1016/j.amjcard.2013.09.020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
594 Pedroso DC, Miranda-Furtado CL, Kogure GS, Meola J, Okuka M, Silva C, Calado RT, Ferriani RA, Keefe DL, dos Reis RM. Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome. Fertil Steril 2015;103:542-7.e2. [PMID: 25467041 DOI: 10.1016/j.fertnstert.2014.10.035] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
595 Corona G, Monami M, Rastrelli G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M. Is Metabolic Syndrome a Useless Category in Subjects with High Cardiovascular Risk? Results from a Cohort Study in Men with Erectile Dysfunction. The Journal of Sexual Medicine 2011;8:504-11. [DOI: 10.1111/j.1743-6109.2010.02126.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
596 Serra A, Romero R, Lopez D, Navarro M, Esteve A, Perez N, Alastrue A, Ariza A. Renal injury in the extremely obese patients with normal renal function. Kidney International 2008;73:947-55. [DOI: 10.1038/sj.ki.5002796] [Cited by in Crossref: 134] [Cited by in F6Publishing: 118] [Article Influence: 10.3] [Reference Citation Analysis]
597 Sarafidis PA. Metabolic syndrome and arterial stiffness: evidence for gender disparity and early effects of non-traditional risk factors? Journal of Hypertension 2007;25:935-8. [DOI: 10.1097/hjh.0b013e32810f2dd7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
598 Shimabukuro M, Higa N, Masuzaki H, Sata M, Ueda S. Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men. Cardiovasc Diabetol 2016;15:77. [PMID: 27188597 DOI: 10.1186/s12933-016-0394-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
599 Jia WP, Wang C, Jiang S, Pan JM. Characteristics of obesity and its related disorders in China. Biomed Environ Sci 2010;23:4-11. [PMID: 20486430 DOI: 10.1016/S0895-3988(10)60025-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
600 Ishizaka N, Ishizaka Y, Hashimoto H, Toda E, Nagai R, Yamakado M. Metabolic Syndrome May Not Associate With Carotid Plaque in Subjects With Optimal, Normal, or High-Normal Blood Pressure. Hypertension 2006;48:411-7. [DOI: 10.1161/01.hyp.0000233466.24345.2e] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
601 Wierzbicki AS, Nishtar S, Lumb PJ, Lambert-hammill M, Crook MA, Marber MS, Gill J. Waist circumference, metabolic syndrome and coronary artery disease in a Pakistani cohort. International Journal of Cardiology 2008;128:77-82. [DOI: 10.1016/j.ijcard.2007.05.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
602 Messiah SE, Arheart KL, Luke B, Lipshultz SE, Miller TL. Relationship between body mass index and metabolic syndrome risk factors among US 8- to 14-year-olds, 1999 to 2002. J Pediatr. 2008;153:215-221. [PMID: 18534237 DOI: 10.1016/j.jpeds.2008.03.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
603 Dupuy A, Jaussent I, Lacroux A, Durant R, Cristol J, Delcourt C. Waist Circumference Adds to the Variance in Plasma C-Reactive Protein Levels in Elderly Patients with Metabolic Syndrome. Gerontology 2008;53:329-39. [DOI: 10.1159/000103555] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
604 Dyck PJ, Dyck PJ, Klein CJ, Weigand SD. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve 2007;36:536-41. [PMID: 17626290 DOI: 10.1002/mus.20846] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
605 Manrique CM, Lastra G, Palmer J, Stump CS, Sowers JR. Hypertension--a treatable component of the cardiometabolic syndrome: challenges for the primary care physician. J Clin Hypertens (Greenwich) 2006;8:12-20. [PMID: 16415636 DOI: 10.1111/j.1524-6175.2006.05379.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
606 Rutkowski P, Klassen A, Sebekova K, Bahner U, Heidland A. Renal disease in obesity: the need for greater attention. J Ren Nutr 2006;16:216-23. [PMID: 16825023 DOI: 10.1053/j.jrn.2006.04.017] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
607 Salsberry PJ, Corwin E, Reagan PB. A complex web of risks for metabolic syndrome: race/ethnicity, economics, and gender. Am J Prev Med 2007;33:114-20. [PMID: 17673098 DOI: 10.1016/j.amepre.2007.03.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
608 Sinclair A, Viljoen A. The metabolic syndrome in older persons. Clin Geriatr Med 2010;26:261-74. [PMID: 20497845 DOI: 10.1016/j.cger.2010.02.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
609 Caro JJ, O'brien JA, Hollenbeak CS, Spackman E, Ben-joseph R, Okamoto LJ, Paramore LC. Economic Burden and Risk of Cardiovascular Disease and Diabetes in Patients with Different Cardiometabolic Risk Profiles. Value in Health 2007;10:S12-20. [DOI: 10.1111/j.1524-4733.2006.00150.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
610 Maclaren NK, Gujral S, Ten S, Motagheti R. Childhood obesity and insulin resistance. Cell Biochem Biophys 2007;48:73-8. [PMID: 17709876 DOI: 10.1007/s12013-007-0017-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
611 Bays H. Adiposopathy, “sick fat,” Ockham’s razor, and resolution of the obesity paradox. Curr Atheroscler Rep. 2014;16:409. [PMID: 24659222 DOI: 10.1007/s11883-014-0409-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
612 Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 2008;7:17. [PMID: 18534019 DOI: 10.1186/1475-2840-7-17] [Cited by in Crossref: 200] [Cited by in F6Publishing: 161] [Article Influence: 15.4] [Reference Citation Analysis]
613 Christian JG, Byers TE, Christian KK, Goldstein MG, Bock BC, Prioreschi B, Bessesen DH. A Computer Support Program that Helps Clinicians Provide Patients with Metabolic Syndrome Tailored Counseling to Promote Weight Loss. Journal of the American Dietetic Association 2011;111:75-83. [DOI: 10.1016/j.jada.2010.10.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
614 Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007;4 Suppl B:S162-77. [PMID: 18156101 DOI: 10.1016/s1550-8579(07)80056-8] [Cited by in Crossref: 125] [Cited by in F6Publishing: 49] [Article Influence: 9.6] [Reference Citation Analysis]
615 Pandit D, Chiplonkar S, Khadilkar A, Kinare A, Khadilkar V. Efficacy of a continuous metabolic syndrome score in Indian children for detecting subclinical atherosclerotic risk. Int J Obes (Lond) 2011;35:1318-24. [PMID: 21772245 DOI: 10.1038/ijo.2011.138] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
616 Ambrosi P, Oddoze C, Nicolay A, Penet-lorec A, Riberi A, Métras D, Portugal H, Habib G. Plasma adiponectin in heart transplant recipients. Clinical Transplantation 2009;23:83-8. [DOI: 10.1111/j.1399-0012.2008.00905.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
617 De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res 2007;4:285-96. [PMID: 18158698 DOI: 10.3132/dvdr.2007.055] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]
618 Wild SH, Byrne CD, Tzoulaki I, Lee AJ, Rumley A, Lowe GD, Fowkes FGR. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study. Atherosclerosis 2009;203:604-9. [DOI: 10.1016/j.atherosclerosis.2008.07.028] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
619 Menotti A, Lanti M, Zanchetti A, Botta G, Laurenzi M, Terradura-vagnarelli O, Mancini M. The role of HDL cholesterol in metabolic syndrome predicting cardiovascular events. The Gubbio population study. Nutrition, Metabolism and Cardiovascular Diseases 2011;21:315-22. [DOI: 10.1016/j.numecd.2009.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
620 Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sciences 2009;84:705-12. [DOI: 10.1016/j.lfs.2009.02.026] [Cited by in Crossref: 507] [Cited by in F6Publishing: 408] [Article Influence: 42.3] [Reference Citation Analysis]
621 Holt RI. Review: Severe mental illness, antipsychotic drugs and the metabolic syndrome. Diabetes & Vascular Disease 2006;6:199-204. [DOI: 10.1177/14746514060060050301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
622 Karelis AD, Lavoie M, Messier V, Mignault D, Garrel D, Prud’homme D, Rabasa-lhoret R. Relationship between the metabolic syndrome and physical activity energy expenditure: a MONET study. Appl Physiol Nutr Metab 2008;33:309-14. [DOI: 10.1139/h07-193] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
623 Blackburn GL, Waltman BA. Pharmacotherapy to reducevisceral fat. Clinical Cornerstone 2005;7:52-60. [DOI: 10.1016/s1098-3597(05)80068-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
624 Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, Sosa JA, Sumner AE, Anton B. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. J Clin Endocrinol Metab 2012;97:E1579-639. [PMID: 22730516 DOI: 10.1210/jc.2012-2043] [Cited by in Crossref: 208] [Cited by in F6Publishing: 158] [Article Influence: 23.1] [Reference Citation Analysis]
625 Pasquali R, Vicennati V, Gambineri A, Pagotto U. Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity. Int J Obes (Lond) 2008;32:1764-79. [PMID: 18838976 DOI: 10.1038/ijo.2008.129] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
626 Francischetti EA, Celoria BM, Francischetti A, Genelhu VA. Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan. Expert Rev Cardiovasc Ther 2008;6:289-303. [PMID: 18327991 DOI: 10.1586/14779072.6.3.289] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
627 Prasad H, Ryan DA, Celzo MF, Stapleton D. Metabolic syndrome: definition and therapeutic implications. Postgrad Med 2012;124:21-30. [PMID: 22314111 DOI: 10.3810/pgm.2012.01.2514] [Cited by in Crossref: 81] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
628 Slama G, Balkau B, Valensi P. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721. Diabetologia 2007;50:1354-5; discussion 1356-7. [PMID: 17437078 DOI: 10.1007/s00125-007-0669-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
629 Kwon Y, Ha J, Paik D, Jin B, Bae K. The relationship between periodontitis and metabolic syndrome among a Korean nationally representative sample of adults: Periodontitis and metabolic syndrome. Journal of Clinical Periodontology 2011;38:781-6. [DOI: 10.1111/j.1600-051x.2011.01756.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
630 Brissot E, Savani BN, Mohty M. Management of High Ferritin in Long-Term Survivors After Hematopoietic Stem Cell Transplantation. Seminars in Hematology 2012;49:35-42. [DOI: 10.1053/j.seminhematol.2011.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
631 Cozzolino M, Urena-torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S; on behalf of the CKD-MBD Working Group of ERA-EDTA. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome? Nephrology Dialysis Transplantation 2014;29:1815-20. [DOI: 10.1093/ndt/gft514] [Cited by in Crossref: 72] [Cited by in F6Publishing: 47] [Article Influence: 10.3] [Reference Citation Analysis]
632 Grassi G, Quarti-trevano F, Seravalle G, Dell'oro R. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases 2007;17:473-81. [DOI: 10.1016/j.numecd.2007.01.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
633 Real JT, Romero P, Martínez Hervas S, Pedro T, Carmena R, Ascaso JF. Papel de la dislipemia aterogénica en el desarrollo del síndrome metabólico. Medicina Clínica 2006;127:321-4. [DOI: 10.1157/13092312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
634 Bo M, Sona A, Astengo M, Fiandra U, Quagliotti E, Brescianini A, Fonte G. Metabolic syndrome in older subjects: Coincidence or clustering? Archives of Gerontology and Geriatrics 2009;48:146-50. [DOI: 10.1016/j.archger.2007.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
635 Morales DD, Punzalan FE, Paz-Pacheco E, Sy RG, Duante CA; National Nutrition And Health Survey: 2003 Group. Metabolic syndrome in the Philippine general population: prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus. Diab Vasc Dis Res 2008;5:36-43. [PMID: 18398811 DOI: 10.3132/dvdr.2008.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
636 Ajjan R, Carter AM, Somani R, Kain K, Grant PJ. Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome. J Thromb Haemost. 2007;5:754-760. [PMID: 17408409 DOI: 10.1111/j.1538-7836.2007.02434.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
637 Fitchett D. The Metabolic Syndrome Is an Important Concept in Therapeutic Decision-Making. Canadian Journal of Cardiology 2015;31:596-600. [DOI: 10.1016/j.cjca.2014.10.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
638 Salminen M, Kuoppamäki M, Vahlberg T, Räihä I, Irjala K, Kivelä SL. Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland. Acta Diabetol 2011;48:157-65. [PMID: 21234614 DOI: 10.1007/s00592-010-0251-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
639 Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis 2007;193:70-6. [PMID: 17011567 DOI: 10.1016/j.atherosclerosis.2006.08.037] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 5.7] [Reference Citation Analysis]
640 Cleaveland S, Haydon DT, Taylor L. Overviews of pathogen emergence: which pathogens emerge, when and why? Curr Top Microbiol Immunol 2007;315:85-111. [PMID: 17848062 DOI: 10.1007/978-3-540-70962-6_5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
641 Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006;38:64-80. [PMID: 16448990 DOI: 10.1080/07853890500401234] [Cited by in Crossref: 117] [Cited by in F6Publishing: 99] [Article Influence: 7.8] [Reference Citation Analysis]
642 Wille E, Scholze J, Alegria E, Ferri C, Langham S, Stevens W, Jeffries D, Uhl-Hochgraeber K. Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy. Eur J Health Econ 2011;12:205-18. [PMID: 20405160 DOI: 10.1007/s10198-010-0223-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
643 Sarafidis PA, Nilsson PM. The metabolic syndrome: a glance at its history. Journal of Hypertension 2006;24:621-6. [DOI: 10.1097/01.hjh.0000217840.26971.b6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 78] [Article Influence: 7.0] [Reference Citation Analysis]
644 Pereira MA, Kottke TE, Jordan C, O'Connor PJ, Pronk NP, Carreón R. Preventing and managing cardiometabolic risk: the logic for intervention. Int J Environ Res Public Health 2009;6:2568-84. [PMID: 20054455 DOI: 10.3390/ijerph6102568] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
645 Liu J, Grundy SM, Wang W, Smith SC, Lena Vega G, Wu Z, Zeng Z, Wang W, Zhao D. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. American Heart Journal 2007;153:552-8. [DOI: 10.1016/j.ahj.2007.01.003] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 7.4] [Reference Citation Analysis]
646 Kurth T, Logroscino G. The Metabolic Syndrome: More Than the Sum of Its Components? Stroke 2008;39:1068-9. [DOI: 10.1161/strokeaha.107.505073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
647 Gloyn AL. Exocrine or endocrine? A circulating pancreatic elastase that regulates glucose homeostasis. Nat Metab 2019;1:853-5. [DOI: 10.1038/s42255-019-0107-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
648 DuBose KD, McKune AJ, Brophy P, Geyer G, Hickner RC. The Relationship Between Physical Activity and the Metabolic Syndrome Score in Children. Pediatr Exerc Sci 2015;27:364-71. [PMID: 25902555 DOI: 10.1123/pes.2014-0134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
649 Brooks NL, Moore KS, Clark RD, Perfetti MT, Trent CM, Combs TP. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? Diabetes Obes Metab. 2007;9:246-258. [PMID: 17391150 DOI: 10.1111/j.1463-1326.2006.00596.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
650 Dunkley AJ, Charles K, Gray LJ, Camosso-Stefinovic J, Davies MJ, Khunti K. Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis. Diabetes Obes Metab 2012;14:616-25. [PMID: 22284386 DOI: 10.1111/j.1463-1326.2012.01571.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 74] [Article Influence: 10.6] [Reference Citation Analysis]
651 Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. American Journal of Physiology-Renal Physiology 2016;311:F1087-108. [DOI: 10.1152/ajprenal.00340.2016] [Cited by in Crossref: 106] [Cited by in F6Publishing: 66] [Article Influence: 21.2] [Reference Citation Analysis]
652 Parrott MD, Greenwood CE. Dietary Influences on Cognitive Function with Aging: From High-Fat Diets to Healthful Eating. Annals of the New York Academy of Sciences 2007;1114:389-97. [DOI: 10.1196/annals.1396.028] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
653 Cull CA, Jensen CC, Retnakaran R, Holman RR. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78. Circulation 2007;116:2119-26. [PMID: 17967769 DOI: 10.1161/CIRCULATIONAHA.107.733428] [Cited by in Crossref: 60] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
654 Euser AM, Dekker FW, Hallan SI. Intrauterine growth restriction: no unifying risk factor for the metabolic syndrome in young adults. European Journal of Cardiovascular Prevention & Rehabilitation 2009;17:317-20. [DOI: 10.1097/hjr.0b013e328331d2c3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
655 Khalaf KI, Taegtmeyer H. Clues from bariatric surgery: reversing insulin resistance to heal the heart. Curr Diab Rep 2013;13:245-51. [PMID: 23354680 DOI: 10.1007/s11892-013-0364-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
656 Bustos P, da Silva AA, Amigo H, Bettiol H, Barbieri MA. Metabolic syndrome in young adults from two socioeconomic Latin American settings. Nutr Metab Cardiovasc Dis 2007;17:581-9. [PMID: 16895751 DOI: 10.1016/j.numecd.2006.06.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
657 Bahchevanov KM, Dzhambov AM, Chompalov KA, Massaldjieva RI, Atanassova PA, Mitkov MD. Contribution of Components of Metabolic Syndrome to Cognitive Performance in Middle-Aged Adults. Arch Clin Neuropsychol 2021;36:498-506. [PMID: 33067992 DOI: 10.1093/arclin/acaa081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
658 Okosun IS, Airhihenbuwa C, Henry TL. Allostatic load, metabolic syndrome and self-rated health in overweight/obese Non-Hispanic White, non-Hispanic Black and Mexican American adults. Diabetes Metab Syndr 2021;15:102154. [PMID: 34186341 DOI: 10.1016/j.dsx.2021.05.027] [Reference Citation Analysis]
659 Kunjara S, McLean P, Rademacher L, Rademacher TW, Fascilla F, Bettocchi S, Scioscia M. Putative Key Role of Inositol Messengers in Endothelial Cells in Preeclampsia. Int J Endocrinol 2016;2016:7695648. [PMID: 27738431 DOI: 10.1155/2016/7695648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
660 Morelli A, Vignozzi L, Maggi M, Adorini L. Farnesoid X receptor activation improves erectile dysfunction in models of metabolic syndrome and diabetes. Biochim Biophys Acta. 2011;1812:859-866. [PMID: 21056655 DOI: 10.1016/j.bbadis.2010.10.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
661 Choi SH, Lim S, Hong ES, Seo JA, Park C, Noh JH, Mok JO, Lee KY, Park JS, Kim DJ, Lee CB, Kim SR, Jang HC. PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome. Clin Endocrinol 2015;82:670-7. [DOI: 10.1111/cen.12580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
662 Szeto CC, Kwan BC, Chow KM, Leung CB, Cheng MS, Law MC, Li PK. Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications. Clin J Am Soc Nephrol 2014;9:779-87. [PMID: 24458080 DOI: 10.2215/CJN.06620613] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
663 Hannon TS, Bacha F, Lee SJ, Janosky J, Arslanian SA. Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes 2006;7:260-6. [DOI: 10.1111/j.1399-5448.2006.00199.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
664 Wang C, Hou X, Bao Y, Pan J, Zuo Y, Zhong W, Jia W, Xiang K. The metabolic syndrome increased risk of cardiovascular events in Chinese--a community based study. Int J Cardiol 2010;139:159-65. [PMID: 19046783 DOI: 10.1016/j.ijcard.2008.10.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
665 Hanchaiphiboolkul S, Suwanwela NC, Poungvarin N, Nidhinandana S, Puthkhao P, Towanabut S, Tantirittisak T, Suwantamee J, Samsen M. Risk of Metabolic Syndrome for Stroke Is Not Greater than the Sum of its Components: Thai Epidemiologic Stroke (TES) Study. Journal of Stroke and Cerebrovascular Diseases 2013;22:e264-70. [DOI: 10.1016/j.jstrokecerebrovasdis.2012.05.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
666 Sourial N, Wolfson C, Zhu B, Quail J, Fletcher J, Karunananthan S, Bandeen-Roche K, Béland F, Bergman H. Correspondence analysis is a useful tool to uncover the relationships among categorical variables. J Clin Epidemiol 2010;63:638-46. [PMID: 19896800 DOI: 10.1016/j.jclinepi.2009.08.008] [Cited by in Crossref: 204] [Cited by in F6Publishing: 101] [Article Influence: 17.0] [Reference Citation Analysis]
667 Ferrara LA, Guida L, Ferrara F, De Luca G, Staiano L, Celentano A, Mancini M. Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome. J Hum Hypertens 2007;21:729-35. [DOI: 10.1038/sj.jhh.1002222] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
668 Schiltz B, Minich DM, Lerman RH, Lamb JJ, Tripp ML, Bland JS. A Science-Based, Clinically Tested Dietary Approach for the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 2009;7:187-92. [DOI: 10.1089/met.2008.0051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
669 Luppino FS, Bouvy PF, Giltay EJ, Penninx BW, Zitman FG. The metabolic syndrome and related characteristics in major depression: inpatients and outpatients compared: metabolic differences across treatment settings. Gen Hosp Psychiatry 2014;36:509-15. [PMID: 25001528 DOI: 10.1016/j.genhosppsych.2014.05.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
670 Tu Y, D'aiuto F, Lin H, Chen Y, Chien K. Relationship between metabolic syndrome and diagnoses of periodontal diseases among participants in a large Taiwanese cohort. J Clin Periodontol 2013;40:994-1000. [DOI: 10.1111/jcpe.12157] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
671 Orlando G, Stratta RJ, Light J. Pancreas transplantation for type 2 diabetes mellitus. Curr Opin Organ Transplant. 2011;16:110-115. [PMID: 21150617 DOI: 10.1097/mot.0b013e3283424d1f] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
672 Hajer GR, van der Graaf Y, Olijhoek JK, Verhaar MC, Visseren FL; SMART Study Group. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart 2007;93:216-20. [PMID: 16952974 DOI: 10.1136/hrt.2006.093971] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
673 Hadaegh F, Shafiee G, Ghasemi A, Sarbakhsh P, Azizi F. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study. Diabetes Res Clin Pract 2010;87:342-7. [PMID: 20004035 DOI: 10.1016/j.diabres.2009.11.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
674 Rhee SY, Park SY, Hwang JK, Son JI, Chin SO, Kim YS, Woo JT. Metabolic syndrome as an indicator of high cardiovascular risk in patients with diabetes: Analyses based on Korea National Health and Nutrition Examination Survey (KNHANES) 2008. Diabetol Metab Syndr 2014;6:98. [PMID: 25264460 DOI: 10.1186/1758-5996-6-98] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
675 Chen W, Srinivasan SR, Berenson GS. Path Analysis of Metabolic Syndrome Components in Black Versus White Children, Adolescents, and Adults: The Bogalusa Heart Study. Annals of Epidemiology 2008;18:85-91. [DOI: 10.1016/j.annepidem.2007.07.090] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
676 Howard W. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Yearbook of Endocrinology 2006;2006:113-4. [DOI: 10.1016/s0084-3741(08)70316-0] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
677 Lee AM, Gurka MJ, DeBoer MD. Trends in Metabolic Syndrome Severity and Lifestyle Factors Among Adolescents. Pediatrics 2016;137:e20153177. [PMID: 26908664 DOI: 10.1542/peds.2015-3177] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 8.2] [Reference Citation Analysis]
678 Yu SS, Castillo DC, Courville AB, Sumner AE. The triglyceride paradox in people of African descent. Metab Syndr Relat Disord. 2012;10:77-82. [PMID: 22224930 DOI: 10.1089/met.2011.0108] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
679 Bianchi C, Penno G, Romero F, Del Prato S, Miccoli R. Treating the metabolic syndrome. Expert Review of Cardiovascular Therapy 2014;5:491-506. [DOI: 10.1586/14779072.5.3.491] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
680 Fischer E, Adolf C, Pallauf A, Then C, Bidlingmaier M, Beuschlein F, Seissler J, Reincke M. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J Clin Endocrinol Metab 2013;98:2513-20. [PMID: 23539730 DOI: 10.1210/jc.2012-3934] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
681 Oda E, Abe M, Kato K, Watanabe K, Veeraveedu PT, Aizawa Y. Gender differences in correlations among cardiovascular risk factors. Gender Medicine 2006;3:196-205. [DOI: 10.1016/s1550-8579(06)80208-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
682 Orias